Ghrelin - A hormone with multiple functions

Frontiers in Neuroendocrinology

Volumn 25, Issue 1, 2004, Pages 27-68

  Korbonits, Márta ^a   Goldstone, Anthony P ^a   Gueorguiev, Maria ^a   Grossman, Ashley B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Appetite; Ghrelin; Growth hormone; Growth hormone secretagogue receptor; Growth hormone secretagogues; Review

Indexed keywords

ESTROGEN; GHRELIN; GLUCOCORTICOID; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; IBUTAMOREN; THYROID HORMONE;

CELL PROLIFERATION; ENDOCRINE FUNCTION; ENERGY TRANSFER; FOOD INTAKE; GASTROINTESTINAL TRACT FUNCTION; GLUCONEOGENESIS; HEART FUNCTION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PARACRINE SIGNALING; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; STOMACH MUCOSA;

EID: 2942530618     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yfrne.2004.03.002     Document Type: Article

References (492)

1. Adams E.F., Buchfelder M., Lei T., Huang B., Hamacher C., Derwahl M., Bowers C.Y., Fahlbusch R. In vitro responses of GH-secreting tumours with and without gsp oncogenes to octreotide, GHRH and growth hormone-releasing peptide. von Werder K., Fahlbusch R. Pituitary Adenomas: From Basic Research to Diagnosis and Therapy. 1996;43-47 Elsevier, Amsterdam
2. Adams E.F., Huang B., Buchfelder M., Howard A.D., Smith R.G., Feighner S.D., Van der Ploeg L.H.T., Bowers C.Y., Fahlbusch R. Presence of growth hormone secretagogue receptor messenger ribonucleic acid in human pituitary tumors and rat GH3 cells. J. Clin. Endocrinol. Metab. 83:1998;638-642
3. ′ -monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: evidence for cross-talk between transduction pathways Mol. Endocrinol. 10:1996;432-438
4. Adams E.F., Lei T., Buchfelder M., Petersen B., Fahlbusch R. Biochemical characteristics of human pituitary somatotrophinomas with or without gsp mutations. J. Clin. Endocrinol. Metab. 80:1995;2077-2081
5. Adeghate E., Ponery A.S. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J. Neuroendocrinol. 14:2002;555-560
6. Aimaretti G., Baffoni C., Broglio F., Janssen J.A., Corneli G., Deghenghi R., van der Lely A.J., Ghigo E., Arvat E. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency. Clin. Endocrinol. (Oxf.). 56:2002;765-771
7. 2) in rat anterior pituitary cells. Endocrinology. 132:1993;1286-1291
8. Andersson U., Filipsson K., Abbott C.R., Woods A., Smith K., Bloom S.R., Carling D., Small C.J. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279:2004;12005-12008
9. Anderwald C., Brabant G., Bernroider E., Horn R., Brehm A., Waldhausl W., Roden M. Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes. 52:2003;1792-1798
10. Andreis P.G., Malendowicz L.K., Trejter M., Neri G., Spinazzi R., Rossi G.P., Nussdorfer G.G. Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells. FEBS Lett. 536:2003;173-179
11. Andrews P.L., Sanger G.J. Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction. Curr. Opin. Pharmacol. 2:2002;650-656
12. Argente J., Chowen J.A., Zeitler P., Clifton D.K., Steiner R.A. Sexual dimorphism of growth hormone-releasing hormone and somatostatin gene expression in the hypothalamus of the rat during development. Endocrinology. 128:1991;2369-2375
13. Ariyasu H., Takaya K., Hosoda H., Iwakura H., Ebihara K., Mori K., Ogawa Y., Hosoda K., Akamizu T., Kojima M., Kangawa K., Nakao K. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific ria for the active form of ghrelin. Endocrinology. 143:2002;3341-3350
14. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., Suda M., Koh T., Natsui K., Toyooka S., Shirakami G., Usui T., Shimatsu A., Doi K., Hosoda H., Kojima M., Kangawa K., Nakao K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin. Endocrinol. Metab. 86:2001;4753-4758
15. Arosio M., Ronchi C.L., Gebbia C., Cappiello V., Beck-Peccoz P., Peracchi M. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J. Clin. Endocrinol. Metab. 88:2003;701-704
16. Arvat E., Di Vito L., Broglio F., Papotti M., Muccioli G., Dieguez C., Casanueva F.F., Deghenghi R., Camanni F., Ghigo E. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J. Endocrinol. Invest. 23:2000;493-495
17. Arvat E., Gianotti L., Broglio F., Maccagno B., Bertagna A., Deghenghi R., Camanni F., Ghigo E. Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post- menopausal women. Eur. J. Endocrinol. 136:1997;483-487
18. Arvat E., Maccario M., Di Vito L., Broglio F., Benso A., Gottero C., Papotti M., Muccioli G., Dieguez C., Casanueva F.F., Deghenghi R., Camanni F., Ghigo E. Endocrine activities of ghrelin, a natural GH secretagogue, in humans: comparison and interactions with hexarelin, a non natural peptidyl GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab. 86:2001;1169-1174
19. Arvat E., Giordano R., Ramunni J., Arnaldi G., Colao A., Deghenghi R., Lombardi G., Mantero F., Camanni F., Ghigo E. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma. J. Clin. Endocrinol. Metab. 83:1998;4207-4211
20. Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M.A., Kasuga M. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut. 52:2003;947-952
21. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Fujimiya M., Katsuura G., Makino S., Fujino M.A., Kasuga M. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology. 74:2001;143-147
22. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., Makino S., Fujimiya M., Niijima A., Fujino M.A., Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 120:2001;337-345
23. Asakawa A., Inui A., Yuzuriha H., Ueno N., Katsuura G., Fujimiya M., Fujino M.A., Niijima A., Meguid M.M., Kasuga M. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology. 124:2003;1325-1336
24. Bagnasco M., Dube M.G., Kalra P.S., Kalra S.P. Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology. 143:2002;4409-4421
25. Bagnasco M., Kalra P.S., Kalra S.P. Ghrelin and leptin pulse discharge in fed and fasted rats. Endocrinology. 143:2002;726-729
26. Bagnasco M., Tulipano G., Melis M.R., Argiolas A., Cocchi D., Muller E.E. Endogenous ghrelin is an orexigenic peptide acting in the arcuate nucleus in response to fasting. Regul. Pept. 111:2003;161-167
27. Bailey A.R.T., Giles M.E., Brown C.H., Bull P.M., MacDonald L.P., Smith L.C., Smith R.G., Leng G., Dickson S.L. Chronic central infusion of growth hormone secretagogues: effects on fos expression and peptide gene expression in the rat arcuate nucleus. Neuroendocrinology. 70:1999;83-92
28. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., Malan D., Baj G., Granata R., Broglio F., Papotti M., Surico N., Bussolino F., Isgaard J., Deghenghi R., Sinigaglia F., Prat M., Muccioli G., Ghigo E., Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol. 159:2002;1029-1037
29. Banks W.A., Tschöp M., Robinson S.M., Heiman M.L. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J. Pharmacol. Exp. Ther. 302:2002;822-827
30. Barkan A.L., Dimaraki E.V., Jessup S.K., Symons K.V., Ermolenko M., Jaffe C.A. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J. Clin. Endocrinol. Metab. 88:2003;2180-2184
31. Barreiro M.L., Gaytan F., Caminos J.E., Pinilla L., Casanueva F.F., Aguilar E., Dieguez C., Tena-Sempere M. Cellular location and hormonal regulation of ghrelin expression in rat testis. Biol. Reprod. 67:2002;1768-1776
32. Barreiro M.L., Pinilla L., Aguilar E., Tena-Sempere M. Expression and homologous regulation of GH secretagogue receptor mRNA in rat adrenal gland. Eur. J. Endocrinol. 147:2002;677-688
33. Basa N.R., Wang L., Arteaga J.R., Heber D., Livingston E.H., Tache Y. Bacterial lipopolysaccharide shifts fasted plasma ghrelin to postprandial levels in rats. Neurosci. Lett. 343:2003;25-28
34. Batterham R.L., Cohen M.A., Ellis S.M., LeRoux C.W., Withers D.J., Frost G.S., Ghatei M.A., Bloom S.R. Inhibition of food intake in obese subjects by peptide YY3-36. N. Engl. J. Med. 349:2003;941-948
35. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., Wren A.M., Brynes A.E., Low M.J., Ghatei M.A., Cone R.D., Bloom S.R. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 418:2002;650-654
36. Batterham R.L., LeRoux C.W., Cohen M.A., Park A.J., Ellis S.M., Patterson M., Frost G.S., Ghatei M.A., Bloom S.R. Pancreatic polypeptide reduces appetite and food intake in humans. J. Clin. Endocrinol. Metab. 88:2003;3989-3992
37. Beaumont N.J., Skinner V.O., Tan T.M., Ramesh B.S., Byrne D.J., MacColl G.S., Keen J.N., Bouloux P.M., Mikhailidis D.P., Bruckdorfer K.R., Vanderpump M.P., Srai K.S. Ghrelin can bind to a species of high-density lipoprotein associated with paraoxonase. J. Biol. Chem. 2003
38. Beck B., Musse N., Stricker-Krongrad A. Ghrelin, macronutrient intake and dietary preferences in long-evans rats. Biochem. Biophys. Res. Commun. 292:2002;1031-1035
39. Bedendi I., Alloatti G., Marcantoni A., Malan D., Catapano F., Ghe C., Deghenghi R., Ghigo E., Muccioli G. Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln(14)-ghrelin. Eur. J. Pharmacol. 476:2003;87-95
40. Bednarek M.A., Feighner S.D., Pong S.S., McKee K.K., Silva M., Warren V.A., Howard A.D., Van der Ploeg L.H.T., Heck J.V. Structure and function studies on the new growth hormone releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 43:2000;4370-4376
41. Bellone S., Rapa A., Vivenza D., Castellino N., Petri A., Bellone J., Me E., Broglio F., Prodam F., Ghigo E., Bona G. Circulating ghrelin levels as function of gender, pubertal status and adiposity in childhood. J. Endocrinol. Invest. 25:2002;RC13-RC15
42. Bennett P.A., Thomas G.B., Howard A.D., Feighner S.D., Van der Ploeg L.H.T., Smith R.G., Robinson I.C.A.F. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology. 138:1997;4552-4557
43. Bercu B.B., Yang S.W., Masuda R., Walker R.F. Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin- releasing hormone. Endocrinology. 130:1992;2579-2586
44. Berti F., Müller E.E., De Gennaro Colonna V., Rossoni G. Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth hormone-deficient rats. Growth Horm. IGF Res. 8:1998;149-152
45. Bisi G., Podio V., Valetto M.R., Broglio F., Bertuccio G., Aimaretti G., Pelosi E., DelRio G., Muccioli G., Ong H., Boghen M.F., Deghenghi R., Ghigo E. Cardiac effects of hexarelin in hypopituitary adults. Eur. J. Pharmacol. 381:1999;31-38
46. Bisi G., Podio V., Valetto M.R., Broglio F., Bertuccio G., Del Rio G., Arvat E., Boghen M.F., Deghenghi R., Muccioli G., Ong H., Ghigo E. Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans. J. Endocrinol. Invest. 22:1999;266-272
47. Bodart V., Bouchard J.F., McNicoll N., Escher E., Carriere P., Ghigo E., Sejlitz T., Sirois M.G., Lamontagne D., Ong H. Identification and characterization of a new growth hormone- releasing peptide receptor in the heart. Circ. Res. 85:1999;796-802
48. Bodart V., Febbraio M., Demers A., McNicoll N., Pohankova P., Perreault A., Sejlitz T., Escher E., Silverstein R.L., Lamontagne D., Ong H. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ. Res. 90:2002;844-849
49. Bowers C.Y. GH releasing peptides - structure and kinetics. J. Pediatr. Endocrinol. 6:1993;21-31
50. Bowers C.Y., Chang J., Momany F.A., Folkers K. Effect of the enkephalins and enkephalin analogues on release of pituitary hormones in vitro. Mol. Endocrinol. 1977;287-292
51. Bresson-Bepoldin L., Odessa M.F., Dufy-Barbe L. GHRP-6 stimulates calcium increase and growth hormone release in human somatotrophs in vivo. Endocrine. 2:1994;793-803
52. Briatore L., Andraghetti G., Cordera R. Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin. Eur. J. Endocrinol. 149:2003;403-406
53. Broglio F., Arvat E., Benso A., Gottero C., Muccioli G., Papotti M., Lely A.J., Deghenghi R., Ghigo E. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J. Clin. Endocrinol. Metab. 86:2001;5083-5086
54. Broglio F., Arvat E., Benso A., Gottero C., Prodam F., Grottoli S., Papotti M., Muccioli G., van der Lely A.J., Deghenghi R., Ghigo E. Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans. J. Clin. Endocrinol. Metab. 87:2002;3783-3790
55. Broglio F., Benso A., Castiglioni C., Gottero C., Prodam F., Destefanis S., Gauna C., van der Lely A.J., Deghenghi R., Bo M., Arvat E., Ghigo E. The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J. Clin. Endocrinol. Metab. 88:2003;1537-1542
56. Broglio F., Benso A., Gottero C., Prodam F., Gauna C., Filtri L., Arvat E., van der Lely A.J., Deghenghi R., Ghigo E. Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans. J. Endocrinol. Invest. 26:2003;192-196
57. Broglio F., Benso A., Valetto M.R., Gottero C., Quaranta L., Podio V., Arvat E., Bobbio M., Bisi G., Ghigo E. Growth hormone-independent cardiotropic activities of growth hormone- releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy. Endocrine. 14:2001;105-108
58. Broglio F., Gottero C., Benso A., Prodam F., Destefanis S., Gauna C., Maccario M., Deghenghi R., van der Lely A.J., Ghigo E. Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. J. Clin. Endocrinol. Metab. 88:2003;4268-4272
59. Broglio F., Koetsveld P.P., Benso A., Gottero C., Prodam F., Papotti M., Muccioli G., Gauna C., Hofland L., Deghenghi R., Arvat E., van der Lely A.J., Ghigo E. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J. Clin. Endocrinol. Metab. 87:2002;4829-4832
60. Brunetti L., Recinella L., Orlando G., Michelotto B., Di Nisio C., Vacca M. Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus. Eur. J. Pharmacol. 454:2002;189-192
61. Bunt J.C., Salbe A.D., Tschop M.H., DelParigi A., Daychild P., Tataranni P.A. Cross-sectional and prospective relationships of fasting plasma ghrelin concentrations with anthropometric measures in pima Indian children. J. Clin. Endocrinol. Metab. 88:2003;3756-3761
62. Caixas A., Bashore C., Nash W., Pi-Sunyer F., Laferrere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J. Clin. Endocrinol. Metab. 87:2002;1902-1906
63. Camina J.P., Carreira M.C., El Messari S., Llorens-cortes C., Smith R.G., Casanueva F.F. Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a. Endocrinology. 145:2004;930-940
64. Caminos J.E., Nogueiras R., Blanco M., Seoane L.M., Bravo S., Alvarez C.V., Garcia-Caballero T., Casanueva F.F., Dieguez C. Cellular distribution and regulation of ghrelin mRNA in the rat pituitary gland. Endocrinology. 144:2003;5089-5097
65. Caminos J.E., Seoane L.M., Tovar S.A., Casanueva F.F., Dieguez C. Influence of thyroid status and growth hormone deficiency on ghrelin. Eur. J. Endocrinol. 147:2002;159-163
66. Caminos J.E., Tena-Sempere M., Gaytan F., Sanchez-Criado J.E., Barreiro M.L., Nogueiras R., Casanueva F.F., Aguilar E., Dieguez C. Expression of ghrelin in the cyclic and pregnant rat ovary. Endocrinology. 144:2003;1594-1602
67. Cappiello V., Ronchi C., Morpurgo P.S., Epaminonda P., Arosio M., Beck-Peccoz P., Spada A. Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients. Eur. J. Endocrinol. 147:2002;189-194
68. Carlini V.P., Monzon M.E., Varas M.M., Cragnolini A.B., Schioth H.B., Scimonelli T.N., de Barioglio S.R. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem. Biophys. Res. Commun. 299:2002;739-743
69. Carmignac D.F., Bennett P.A., Robinson I.C.A.F. Effects of growth hormone secretagogues on prolactin release in anesthetized dwarf (dw/dw) rats. Endocrinology. 139:1998;3590-3596
70. Cassoni P., Papotti M., Catapano F., Ghe C., Deghenghi R., Ghigo E., Muccioli G. Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue. J. Endocrinol. 165:2000;139-146
71. Cassoni P., Papotti M., Ghe C., Catapano F., Sapino A., Graziani A., Deghenghi R., Reissmann T., Ghigo E., Muccioli G. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J. Clin. Endocrinol. Metab. 86:2001;1738-1745
72. Callahan H.S., Cummings D.E., Pepe M.S., Breen P.A., Matthys C.C., Weigle D.S. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. J. Clin. Endocrinol. Metab. 89:2004;1319-1324
73. Chan J.L., Bullen J., Lee J.H., Yiannakouris N., Mantzoros C.S. Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J. Clin. Endocrinol. Metab. 89:2004;335-343
74. Chang L., Du J.B., Gao L.R., Pang Y.Z., Tang C.S. Effect of ghrelin on septic shock in rats. Acta Pharmacol. Sin. 24:2003;45-49
75. Chang L., Zhao J., Yang J., Zhang Z., Du J., Tang C. Therapeutic effects of ghrelin on endotoxic shock in rats. Eur. J. Pharmacol. 473:2003;171-176
76. Chanoine J.P., Yeung L.P., Wong A.C. Umbilical cord ghrelin concentrations in Asian and Caucasian neonates. Horm. Res. 60:2003;116-120
77. Chanoine J.P., Yeung L.P., Wong A.C., Birmingham C.L. Immunoreactive ghrelin in human cord blood: relation to anthropometry, leptin, and growth hormone. J. Pediatr. Gastroenterol. Nutr. 35:2002;282-286
78. Chapman I.M., Bach M.A., Van Cauter E., Farmer M., Krupa D.A., Taylor A.M., Schilling L.M., Cole K.Y., Skiles E.H., Pezzoli S.S., Hartman M.L., Veldhuis J.D., Gromley G.J., Thorner M.O. Stimulation of the growth hormone (GH)-insulin-like growth factor axis by daily oral administration of a GH-secretagogue (MK-0677) in healthy elderly subjects. J. Clin. Endocrinol. Metab. 81:1996;4249-4257
79. Chen C. Growth hormone secretagogue actions on the pituitary gland: multiple receptors for multiple ligands? Clin. Exp. Pharmacol. Physiol. 27:2000;323-329
80. ′ -monophosphate accumulation in rat pituitary cell culture Endocrinology. 124:1989;2791-2798
81. 2-induced growth hormone release from rat primary pituitary cells. Endocrinology. 129:1991;3337-3342
82. Cheng K., Chan W.W., Butler B., Wei L., Schoen W.R., Wyvratt M.J. Jr., Fisher M.H., Smith R.G. Stimulation of growth hormone release from rat primary pituitary cells by L-692, 429, a novel non-peptidyl GH secretagogue. Endocrinology. 132:1993;2729-2731
83. Cheng K., Chan W.W.S., Butler B., Wei L., Smith R.G. A novel non-peptidyl growth hormone secretagogue. Horm. Res. 40:1993;109-115
84. Cheng J., Wu T.J., Butler B., Cheng K. Growth hormone releasing peptides: a comparison of the growth hormone releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary cells. Life Sci. 60:1997;1385-1392
85. Choi K., Roh S.G., Hong Y.H., Shrestha Y.B., Hishikawa D., Chen C., Kojima M., Kangawa K., Sasaki S. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology. 144:2003;754-759
86. Cittadini A., Cuocolo A., Merola B., Fazio S., Sabatini D., Nicolai E., Colao A., Longobardi S., Lombardi G., Sacca L. Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am. J. Physiol. 267:1994;E219-E225
87. Clark R.G., Carlsson L., Trojnar J., Robinson I.C.A.F. The effect of growth hormone-releasing peptide and growth hormone-releasing factor on conscious and anaesthetized rats. J. Neuroendocrinology. 1:1989;249-255
88. Codd E.E., Shu A.Y.L., Walker R.F. Binding of growth hormone-releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology. 28:1989;1139-1144
89. Cohen M.A., Ellis S.M., LeRoux C.W., Batterham R.L., Park A., Patterson M., Frost G.S., Ghatei M.A., Bloom S.R. Oxyntomodulin suppresses appetite and reduces food intake in humans. J. Clin. Endocrinol. Metab. 88:2003;4696-4701
90. Colombo M., Gregersen S., Xiao J., Hermansen K. Effects of ghrelin and other neuropeptides (CART, MCH, Orexin A and B, and GLP-1) on the release of insulin from isolated rat islets. Pancreas. 27:2003;161-166
91. Conley L.K., Teik J.A., Deghenghi R., Imbimbo B.P., Giustina A., Locatelli V., Wehrenberg W.B. Mechanism of action of hexarelin and GHRP-6 - analysis of the involvement of GHRH and somatostatin in the rat. Neuroendocrinology. 61:1995;44-50
92. Copinschi G., Leproult R., VanOnderbergen A., Caufriez A., Cole K.Y., Schilling L.M., Mendel C.M., DeLepeleire I., Bolognese J.A., VanCauter E. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man. Neuroendocrinology. 66:1997;278-286
93. Copinschi G., VanOnderbergen A., L'Hermite-Baleraux M., Mendel C.M., Caufriez A., Leproult R., Bolognese J.A., De Smet M., Thoren M., Van Cauter E. Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-h GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. J. Clin. Endocrinol. Metab. 81:1996;2776-2782
94. Corbetta S., Peracchi M., Cappiello V., Lania A., Lauri E., Vago L., Beck-Peccoz P., Spada A. Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J. Clin. Endocrinol. Metab. 88:2003;3117-3120
95. Cortelazzi D., Cappiello V., Morpurgo P.S., Ronzoni S., Nobile De Santis M.S., Cetin I., Beck-Peccoz P., Spada A. Circulating levels of ghrelin in human fetuses. Eur. J. Endocrinol. 149:2003;111-116
96. Cowley M.A. Hypothalamic melanocortin neurons integrate signals of energy state. Eur. J. Pharmacol. 480:2003;3-11
97. Cowley M.A., Pronchuk N., Fan W., Dinulescu D.M., Colmers W.F., Cone R.D. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron. 24:1999;155-163
98. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., Strasburger C.J., Bidlingmaier M., Esterman M., Heiman M.L., Garcia-Segura L.M., Nillni E.A., Mendez P., Low M.J., Sotonyi P., Friedman J.M., Liu H., Pinto S., Colmers W.F., Cone R.D., Horvath T.L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 37:2003;649-661
99. Cummings D.E., Clement K., Purnell J.Q., Vaisse C., Foster K.E., Frayo R.S., Schwartz M.W., Basdevant A., Weigle D.S. Elevated plasma ghrelin levels in Prader-Willi syndrome. Nat. Med. 8:2002;643-644
100. Cummings D.E., Frayo R.S., Marmonier C., Aubert R., Chapelot D. Plasma ghrelin levels and hunger scores among humans initiating meals voluntarily in the absence of time- and food-related cues. Am. J. Physiol. Endocrinol. Metab. 2004
101. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 50:2001;1714-1719
102. Cummings D.E., Shannon M.H. Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J. Clin. Endocrinol. Metab. 88:2003;2999-3002
103. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., Purnell J.Q. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346:2002;1623-1630
104. ′ -monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors Endocrinology. 143:2002;4570-4582
105. Dall R., Kanaley J., Hansen T.K., Moller N., Christiansen J.S., Hosoda H., Kangawa K., Jorgensen J.O. Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients. Eur. J. Endocrinol. 147:2002;65-70
106. Dass N.B., Munonyara M., Bassil A.K., Hervieu G.J., Osbourne S., Corcoran S., Morgan M., Sanger G.J. Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin. Neuroscience. 120:2003;443-453
107. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., Matsukura S., Kangawa K., Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 141:2000;4255-4261
108. Date Y., Murakami N., Kojima M., Kuroiwa T., Matsukura S., Kangawa K., Nakazato M. Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem. Biophys. Res. Commun. 275:2000;477-480
109. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., Kangawa K., Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology. 123:2002;1120-1128
110. Date Y., Nakazato M., Hashiguchi S., Dezaki K., Mondal M.S., Hosoda H., Kojima M., Kangawa K., Arima T., Matsuo H., Yada T., Matsukura S. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes. 51:2002;124-129
111. Date Y., Nakazato M., Murakami N., Kojima M., Kangawa K., Matsukura S. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem. Biophys. Res. Commun. 280:2001;904-907
112. Davis M.E., Pemberton C.J., Yandle T.G., Lainchbury J.G., Rademaker M.T., Nicholls M.G., Frampton C.M., Richards A.M. Urocortin-1 infusion in normal humans. J. Clin. Endocrinol. Metab. 89:2004;1402-1409
113. De Gennaro Colonna V., Rossoni G., Bernareggi M., Müller E.E., Berti F. Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin. Eur. J. Pharmacol. 334:1997;201-207
114. Deghenghi R., Papotti M., Ghigo E., Muccioli G. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland. J. Endocrinol. Invest. 24:2001;RC1-RC3
115. DelParigi A., Tschöp M., Heiman M.L., Salbe A.D., Vozarova B., Sell S.M., Bunt J.C., Tataranni P.A. High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 87:2002;5461-5464
116. DeMarinis L., Mancini A., Valle D., Izzi D., Bianchi A., Gentilella R., Giampietro A., Desenzani P., Giustina A. Role of food intake in the modulation of hexarelin-induced growth hormone release in normal human subjects. Horm. Metab. Res. 32:2000;152-156
117. Dickson S.L., Doutrelantviltart O., Leng G. GH-deficient dw/dw rats and lit/lit mice show increased fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6. J. Endocrinol. 146:1995;519-526
118. Dickson S.L., Leng G., Dyball R.E.J., Smith R.G. Central actions of peptide and non-peptide growth hormone secretagogues in the rat. Neuroendocrinology. 61:1995;36-43
119. Dickson S.L., Leng G., Robinson I.C.A.F. Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neuroscience. 53:1993;303-306
120. Dickson S.L., Luckman S.M. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurones in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology. 138:1997;771-777
121. Dimaraki E.V., Jaffe C.A., Bowers C.Y., Marbach P., Barkan A.L. Pulsatile and nocturnal growth hormone secretions in men do not require periodic declines of somatostatin. Am. J. Physiol. Endocrinol. Metab. 285:2003;E163-E170
122. V.M. Dixit, E.M. Schaffer, D.D.Taub. Ghrelin is expressed and secreted from human T lymphocytes and inhibits activation and leptin induced inflammatory cytokine expression via functional, lipid raft-associated growth hormone secretagogue receptors (GHS-R), in: Proceedings of the 85th Annual Meeting of the Endocrine Society, OR51-3, 2003
123. Djurhuus C.B., Hansen T.K., Gravholt C., ORskov L., Hosoda H., Kangawa K., Jorgensen J.O., Holst J.J., Schmitz O. Circulating levels of ghrelin and GLP-1 are inversely related during glucose ingestion. Horm. Metab. Res. 34:2002;411-413
124. Dornonville d.l.C., Bjorkqvist M., Sandvik A.K., Bakke I., Zhao C., Chen D., Hakanson R. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul. Pept. 99:2001;141-150
125. Drisko J.E., Faidley T.D., Chang C.H., Zhang D., Nicolich S., Hora D.F., McNamara L., Rickes E., Abribat T., Smith R.G., Hickey G.J. Hypophyseal-portal concentrations of growth hormone-releasing factor and somatostatin in conscious pigs: relationship to production of spontaneous growth hormone pulses. Proc. Soc. Exp. Biol. Med. 217:1998;188-196
126. Duxbury M.S., Waseem T., Ito H., Robinson M.K., Zinner M.J., Ashley S.W., Whang E.E. Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem. Biophys. Res. Commun. 309:2003;464-468
127. Eden-Engstrom B., Burman P., Holdstock C., Karlsson F.A. Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. J. Clin. Endocrinol. Metab. 88:2003;5193-5198
128. Egido E.M., Rodriguez-Gallardo J., Silvestre R.A., Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur. J. Endocrinol. 146:2002;241-244
129. Elphick M.R., Egertova M. The neurobiology and evolution of cannabinoid signalling. Philos. Trans. R. Soc. Lond B Biol. Sci. 356:2001;381-408
130. Emoto N., Ohmura E., Isozaki O., Tsushima T., Shizume K., Demura H. Phorbol ester, not growth hormone-releasing factor, consistently stimulates growth hormone release from somatotroph adenomas in culture. Clin. Endocrinol. (Oxf.). 34:1991;377-382
131. English P.J., Ghatei M.A., Malik I.A., Bloom S.R., Wilding J.P. Food fails to suppress ghrelin levels in obese humans. J. Clin. Endocrinol. Metab. 87:2002;2984-2987
132. Enomoto M., Nagaya N., Uematsu M., Okumura H., Nakagawa E., Ono F., Hosoda H., Oya H., Kojima M., Kanmatsuse K., Kangawa K. Cardiovascular and hormonal effects of subcutaneous administration of Ghrelin, a novel growth hormone-releasing peptide, in healthy humans. Clin. Sci. (Lond.). 105:2003;431-435
133. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide-Y. Nature. 381:1996;415-418
134. Faraj M., Havel P.J., Phelis S., Blank D., Sniderman A.D., Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese
135. Farquhar J., Heiman M., Wong A.C., Wach R., Chessex P., Chanoine J.P. Elevated umbilical cord ghrelin concentrations in small for gestational age neonates. J. Clin. Endocrinol. Metab. 88:2003;4324-4327
136. Faulconbridge L.F., Cummings D.E., Kaplan J.M., Grill H.J. Hyperphagic effects of brainstem ghrelin administration. Diabetes. 52:2003;2260-2265
137. Fazio S., Sabatini D., Capaldo B., Vigorito C., Giordano A., Guida R., Pardo F., Biondi B., Saccà L. Preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N. Engl. J. Med. 334:1996;809-814
138. Febbraio M., Abumrad N.A., Hajjar D.P., Sharma K., Cheng W., Pearce S.F., Silverstein R.L. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274:1999;19055-19062
139. Fehrentz J.A., Martinez J., Boeglin D., Guerlavais V., Deghenghi R. Growth hormone secretagogues: Past, present and future. Idrugs. 5:2002;804-814
140. Feighner S.D., Howard A.D., Prendergast K., Palyha O.C., Hreniuk D.L., Nargund R., Underwood D.J., Tata J.R., Dean D.C., Tan C.P., McKee K.K., Woods J.W., Patchett A.A., Smith R.G., Van der Ploeg L.H.T. Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues. Mol. Endocrinol. 12:1998;137-145
141. Feighner S.D., Tan C.P., McKee K.K., Palyha O.C., Hreniuk D.L., Pong S.S., Austin C.P., Figueroa D., MacNeil D., Cascieri M.A., Nargund R., Bakshi R., Abramovitz M., Stocco R., Kargman S., ONeill G., Van der Ploeg L.H.T., Evans J., Patchett A.A., Smith R.G., Howard A.D., O'Neill G., Van der Ploeg L.H.T. Receptor for motilin identified in the human gastrointestinal system. Science. 284:1999;2184-2188
142. Flanagan D.E., Evans M.L., Monsod T.P., Rife F., Heptulla R.A., Tamborlane W.V., Sherwin R.S. The influence of insulin on circulating ghrelin. Am. J. Physiol. Endocrinol. Metab. 284:2003;E313-E316
143. Fletcher T.P., Thomas G.B., Clarke I.J. Growth hormone-releasing hormone and somatostatin concentrations in the hypophysial portal blood of conscious sheep during the infusion of growth hormone-releasing peptide-6. Domest. Anim. Endocrinol. 13:1996;251-258
144. Freda P.U., Reyes C.M., Conwell I.M., Sundeen R.E., Wardlaw S.L. Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy. J. Clin. Endocrinol. Metab. 88:2003;2037-2044
145. Frieboes R.M., Murck H., Maier P., Schier T., Holsboer F., Steiger A. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology. 61:1995;584-589
146. Fujii R., Hosoya M., Fukusumi S., Kawamata Y., Habata Y., Hinuma S., Onda H., Nishimura O., Fujino M. Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3. J. Biol. Chem. 275:2000;21068-21074
147. Fujino K., Inui A., Asakawa A., Kihara N., Fujimura M., Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J. Physiol. (Lond.). 550:2003;227-240
148. Furuta M., Funabashi T., Kimura F. Intracerebroventricular administration of ghrelin rapidly suppresses pulsatile luteinizing hormone secretion in ovariectomized rats. Biochem. Biophys. Res. Commun. 288:2001;780-785
149. Garcia A., Alvarez C.V., Smith R.G., Dieguez C. Regulation of pit-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor. Mol. Endocrinol. 15:2001;1484-1495
150. Gaskin F.S., Farr S.A., Banks W.A., Kumar V.B., Morley J.E. Ghrelin-induced feeding is dependent on nitric oxide. Peptides. 24:2003;913-918
151. Gaytan F., Barreiro M.L., Caminos J.E., Chopin L.K., Herington A.C., Morales C., Pinilla L., Paniagua R., Nistal M., Casanueva F.F., Aguilar E., Dieguez C., Tena-Sempere M. Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J. Clin. Endocrinol. Metab. 89:2004;400-409
152. Gaytan F., Barreiro M.L., Chopin L.K., Herington A.C., Morales C., Pinilla L., Casanueva F.F., Aguilar E., Dieguez C., Tena-Sempere M. Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor in the cyclic human ovary. J. Clin. Endocrinol. Metab. 88:2003;879-887
153. Geelissen S.M., Beck I.M., Darras V.M., Kuhn E.R., Van Der G.S. Distribution and regulation of chicken growth hormone secretagogue receptor isoforms. Gen. Comp. Endocrinol. 134:2003;167-174
154. Geloneze B., Tambascia M.A., Pilla V.F., Geloneze S.R., Repetto E.M., Pareja J.C. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes. Surg. 13:2003;17-22
155. Ghe C., Cassoni P., Catapano F., Marrocco T., Deghenghi R., Ghigo E., Muccioli G., Papotti M. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology. 143:2002;484-491
156. Ghigo E., Arvat E., Broglio F., Giordano R., Gianotti L., Muccioli G., Papotti M., Graziani A., Bisi G., Deghenghi R., Camanni F. Endocrine and non-endocrine activities of growth hormone secretagogues in humans. Horm. Res. 51:1999;9-15
157. Ghigo E., Arvat E., Ramunni J., Colao A., Gianotti L., Deghenghi R., Lombardi G., Camanni F. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. J. Clin. Endocrinol. Metab. 82:1997;2439-2444
158. Glavaski-Joksimovic A., Jeftinija K., Scanes C.G., Anderson L.L., Jeftinija S. Stimulatory effect of ghrelin on isolated porcine somatotropes. Neuroendocrinology. 77:2003;367-379
159. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 87:2002;2988-2991
160. Gokcel A., Gumurdulu Y., Kayaselcuk F., Serin E., Ozer B., Ozsahin A.K., Guvener N. Helicobacter pylori has no effect on plasma ghrelin levels. Eur. J. Endocrinol. 148:2003;423-426
161. Goldstone A.P. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol. Metab. 15:2004;12-20
162. A.P. Goldstone, M. Patterson, M. Kalingag, M.A. Ghatei, A.E. Brynes, S.R. Bloom, A.B. Grossman, M. Korbonits, What is the cause of hyperghrelinemia in Prader-Willi syndrome and is it seen in hypothalamic obesity? in: Proceedings of the 86th Annual Meeting of the Endocrine Society, P1-351, 2004
163. Goldstone A.P., Thomas E.L., Brynes A.E., Castroman G., Edwards R., Ghatei M.A., Frost G., Holland A.J., Grossman A.B., Korbonits M., Bloom S.R., Bell J.D. Elevated fasting plasma ghrelin in Prader-Willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance. J. Clin. Endocrinol. Metab. 89:2004;1718-1726
164. Goldstone A.P., Unmehopa U.A., Bloom S.R., Swaab D.F. Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. J. Clin. Endocrinol. Metab. 87:2002;927-937
165. Goldstone A.P., Unmehopa U.A., Swaab D.F. Hypothalamic growth hormone-releasing hormone (GHRH) cell number is increased in human illness, but is not reduced in Prader-Willi syndrome or obesity. Clin. Endocrinol. (Oxf.). 58:2003;743-755
166. Gondo R.G., Aguiar-Oliveira M.H., Hayashida C.Y., Toledo S.P., Abelin N., Levine M.A., Bowers C.Y., Souza A.H., Pereira R.M., Santos N.L., Salvatori R. Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor. J. Clin. Endocrinol. Metab. 86:2001;3279-3283
167. Greenman Y., Golani N., Gilad S., Yaron M., Limor R., Stern N. Ghrelin secretion is modulated in a nutrient- and gender-specific manner. Clin. Endocrinol. (Oxf.). 60:2004;382-388
168. Gualillo O., Caminos J.E., Blanco M., Garcia-Caballero T., Kojima M., Kangawa K., Dieguez C., Casanueva F.F. Ghrelin, a novel placental-derived hormone. Endocrinology. 142:2001;788-794
169. Gualillo O., Caminos J.E., Kojima M., Kangawa K., Arvat E., Ghigo E., Casanueva F.F., Dieguez C. Gender and gonadal influences on ghrelin mRNA levels in rat stomach. Eur. J. Endocrinol. 144:2001;687-690
170. Gualillo O., Caminos J.E., Nogueiras R., Seoane L.M., Arvat E., Ghigo E., Casanueva F.F., Dieguez C. Effect of food restriction on ghrelin in normal-cycling female rats and in pregnancy. Obes. Res. 10:2002;682-687
171. M. Gueorguiev, C. Lecoeur, J.C. Blair, S. Leibel, M.O. Savage, A.B. Grossman, P. Froguel, M. Korbonits, Ghrelin and growth hormone secretagogue receptor (GHS-R) polymorphisms and idiopathic short stature, in: Proceedings of the 85th Annual Meeting of the Endocrine Society, P1-484, 2003
172. Guan X.-M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J.S., Smith R.G., Van der Ploeg L.H.T., Howard A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol. Brain Res. 48:1997;23-29
173. M. Gueorguiev, E. O'Grady, C. Lecoeur, A.B. Grossman, P. Froguel, M. Korbonits, Identification of single nucleotide polymorphisms in the ghrelin gene in tall, obese children, in: Proceedings of the 84th Annual Meeting of the Endocrine Society, 2002
174. Guillaume V., Magnan E., Cataldi M., Dutuor A., Sauze N., Conte-Delvox B., Oliver C., Lenaerts V., Deghenghi R. GH-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology. 135:1994;1073-1076
175. Hansen B.S., Ankersen M., Hansen T.K., Raun K., Nielsen K.K., Lau J., Peschke B., Lundt B.F., Thogersen H., Johansen N.L., Madsen K., Andersen P.H. Pharmakokinetics of NN703. Eur. J. Endocrinol. 141:1999;180-189
176. Hansen T.K., Dall R., Hosoda H., Kojima M., Kangawa K., Christiansen J.S., Jorgensen J.O. Weight loss increases circulating levels of ghrelin in human obesity. Clin. Endocrinol. (Oxf.). 56:2002;203-206
177. Hanusch-Enserer U., Brabant G., Roden M. Ghrelin concentrations in morbidly obese patients after adjustable gastric banding. N. Engl. J. Med. 348:2003;2159-2160
178. Haqq A.M., Farooqi I.S., O'Rahilly S., Stadler D.D., Rosenfeld R.G., Pratt K.L., LaFranchi S.H., Purnell J.Q. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 88:2003;174-178
179. Haqq A.M., Stadler D.D., Jackson R.H., Rosenfeld R.G., Purnell J.Q., LaFranchi S.H. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 88:2003;2206-2212
180. Haqq A.M., Stadler D.D., Rosenfeld R.G., Pratt K.L., Weigle D.S., Frayo R.S., LaFranchi S.H., Cummings D.E., Purnell J.Q. Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 88:2003;3573-3576
181. Harsch I.A., Konturek P.C., Koebnick C., Kuehnlein P.P., Fuchs F.S., Pour S.S., Wiest G.H., Hahn E.G., Lohmann T., Ficker J.H. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur. Respir. J. 22:2003;251-257
182. Hataya Y., Akamizu T., Hosoda H., Kanamoto N., Moriya K., Kangawa K., Nakao K. Alterations of plasma ghrelin levels in rats with lipopolysaccharide- induced wasting syndrome and effects of ghrelin treatment on the syndrome. Endocrinology. 144:2003;5365-5371
183. Hataya Y., Akamizu T., Takaya K., Kanamoto N., Ariyasu H., Saijo M., Moriyama K., Shimatsu A., Kojima M., Kangawa K., Nakao K. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J. Clin. Endocrinol. Metab. 86:2001;4552-4555
184. Hattori N., Saito T., Yagyu T., Jiang B.H., Kitagawa K., Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J. Clin. Endocrinol. Metab. 86:2001;4284-4291
185. Hayashida T., Nakahara K., Mondal M.S., Date Y., Nakazato M., Kojima M., Kangawa K., Murakami N. Ghrelin in neonatal rats: distribution in stomach and its possible role. J. Endocrinol. 173:2002;239-245
186. Hayashi S., Kaji H., Ohashi S., Abe H., Chihara K. Effect of intravenous administration of growth hormone-releasing peptide on plasma growth hormone in patients with short stature. Clin. Paediatr. Endocrinol. 2(Suppl. 2):1993;69-74
187. Herrington J., Hille B. Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotropes by 2 mechanisms. Endocrinology. 135:1994;1100-1108
188. Herzog H. Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. Eur. J. Pharmacol. 480:2003;21-29
189. Hewson A.K., Dickson S.L. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J. Neuroendocrinol. 12:2000;1047-1049
190. Hewson A.K., Tung L.Y., Connell D.W., Tookman L., Dickson S.L. The rat arcuate nucleus integrates peripheral signals provided by leptin, insulin, and a ghrelin mimetic. Diabetes. 51:2002;3412-3419
191. Hewson A.K., Viltart O., McKenzie D.N., Dyball R.E.J., Dickson S.L. GHRP-6-induced changes in electrical activity of single cells in the arcuate, ventromedial and periventricular nucleus neurones of a hypothalamic slice preparation in vitro. J. Neuroendocrinol. 11:1999;919-923
192. Hickey G.J., Drisko J., Faidley T., Chang C., Anderson L.L., Nicolich S., McGuire L., Rickes E., Krupa D., Feeney W., Friscino B., Cunningham P., Fraizer E., Chen H., Laroque P., Smith R.G. Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692, 585. J. Endocrinol. 148:1996;371-380
193. Hickey G.J., Jacks T.M., Schleim K.D., Frazier E., Chen H.Y., Krupa D., Feeney W., Nargund R.P., Patchett A.A., Smith R.G. Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles. J. Endocrinol. 152:1997;183-192
194. Hinney A., Hoch A., Geller F., Schafer H., Siegfried W., Goldschmidt H., Remschmidt H., Hebebrand J. Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J. Clin. Endocrinol. Metab. 87:2002;2716-2719
195. Holdstock C., Engstrom B.E., Ohrvall M., Lind L., Sundbom M., Karlsson F.A. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J. Clin. Endocrinol. Metab. 88:2003;3177-3183
196. Holdstock C., Ludvigsson J., Karlsson F.A. Abnormal ghrelin secretion in new onset childhood Type 1 diabetes. Diabetologia. 2003
197. Holst B., Cygankiewicz A., Halkjar J.T., Ankersen M., Schwartz T.W. High Constitutive Signaling of the Ghrelin Receptor-Identification of a Potent Inverse Agonist. Mol. Endocrinol. 17:2003;2201-2210
198. Horikawa R., Tachibana T., Katsumata N., Ishikawa H., Tanaka T. Regulation of pituitary growth hormone-secretagogue and growth hormone-releasing hormone receptor RNA expression in young dwarf rats. Endocr. J. 47:2000;S53-S56
199. Hosoda H., Kojima M., Matsuo H., Kangawa K. Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J. Biol. Chem. 275:2000;21995-22000
200. Hosoda H., Kojima M., Matsuo H., Kangawa K. Ghrelin and des-acyl ghrelin: Two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophys. Res. Commun. 279:2000;909-913
201. Hosoda H., Kojima M., Mizushima T., Shimizu S., Kangawa K. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J. Biol. Chem. 278:2003;64-70
202. Houslay M.D. Crosstalk: a pivotal role for the protein kinase C in modulating relationships between signal transduction pathways. J. Biol. Chem. 264:1998;8802-8810
203. Howard A.D., Feighner S.D., Cully D.F., Liberator P.A., Arena J.P., Rosenblum C.I., Hamelin M.J., Hreniuk D.L., Palyha O.C., Anderson J., Paress P.S., Diaz C., Chou M., Liu K., KuljuMcKee K., Pong S.-S., Chaung L.Y., Elbrecht A., Dashkevicz M., Heavens R., Rigby M., Sirinathsinghji D.J.S., Dean D.C., Melillo D.G., Patchett A.A., Nargund R., Griffin P.R., DeMartino J.A., Gupta S.K., Schaeffer J.M., Smith R.G., Van der Ploeg L.H.T. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273:1996;974-977
204. Howard A.D., Wang R., Pong S.S., Mellin T.N., Strack A., Guan X.M., Zeng Z., Williams D.L. Jr., Feighner S.D., Nunes C.N., Murphy B., Stair J.N., Yu H., Jiang Q., Clements M.K., Tan C.P., McKee K.K., Hreniuk D.L., McDonald T.P., Lynch K.R., Evans J.F., Austin C.P., Caskey C.T., Van der Ploeg L.H.T., Liu Q. Identification of receptors for neuromedin U and its role in feeding. Nature. 406:2000;70-74
205. Ikezaki A., Hosoda H., Ito K., Iwama S., Miura N., Matsuoka H., Kondo C., Kojima M., Kangawa K., Sugihara S. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes. 51:2002;3408-3411
206. Ilson B.E., Jorkasky D.K., Curnow R.T., Stote R.M. Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J. Clin. Endocrinol. Metab. 69:1989;212-214
207. Imazio M., Bobbio M., Broglio F., Benso A., Podio V., Valetto M.R., Bisi G., Ghigo E., Trevi G.P. GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy. Eur. J. Heart Fail. 4:2002;185-191
208. Iniguez G., Ong K., Pena V., Avila A., Dunger D., Mericq V. Fasting and post-glucose ghrelin levels in SGA infants: relationships with size and weight gain at one year of age. J. Clin. Endocrinol. Metab. 87:2002;5830-5833
209. Ishii S., Kamegai J., Tamura H., Shimizu T., Sugihara H., Oikawa S. Role of ghrelin in streptozotocin-induced diabetic hyperphagia. Endocrinology. 143:2002;4934-4937
210. Iwakura H., Hosoda K., Doi R., Komoto I., Nishimura H., Son C., Fujikura J., Tomita T., Takaya K., Ogawa Y., Hayashi T., Inoue G., Akamizu T., Hosoda H., Kojima M., Kangawa K., Imamura M., Nakao K. Ghrelin expression in islet cell tumors: augmented expression of ghrelin in a case of glucagonoma with multiple endocrine neoplasm type I. J. Clin. Endocrinol. Metab. 87:2002;4885-4888
211. Janssen J.A., Der Toorn F.M., Hofland L.J., van Koetsveld P., Broglio F., Ghigo E., Lamberts S.W., Jan V.D.L. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur. J. Endocrinol. 145:2001;711-716
212. Jeffery P.L., Herington A.C., Chopin L.K. Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J. Endocrinol. 172:2002;R7-R11
213. Jeffery P.L., Herington A.C., Chopin L.K. The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer. Cytok. Growth Factor Rev. 14:2003;113-122
214. Kaji H., Kishimoto M., Kirimura T., Iguchi G., Murata M., Yoshioka S., Iida K., Okimura Y., Yoshimoto Y., Chihara K. Hormonal regulation of the human ghrelin receptor gene transcription. Biochem. Biophys. Res. Commun. 284:2001;660-666
215. ′ -flanking region of the human growth hormone secretagogue receptor gene J. Biol. Chem. 273:1998;33885-33888
216. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20:1999;68-100
217. Kamegai J., Hasegawa O., Sugihara H., Wakabayashi I. The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus. Mol. Brain Res. 39:1996;153-159
218. Kamegai J., Minami S., Sugihara H., Hasegawa O., Higuchi H., Wakabayashi I. Growth hormone receptor gene is expressed in neuropeptide Y neurons in hypothalamic arcuate nucleus of rats. Endocrinology. 137:1996;2109-2112
219. Kamegai J., Tamura H., Ishii S., Sugihara H., Wakabayashi I. Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression. J. Neuroendocrinol. 13:2001;275-278
220. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Oikawa S. Regulation of the ghrelin gene: growth hormone-releasing hormone upregulates ghrelin mRNA in the pituitary. Endocrinology. 142:2001;4154-4157
221. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes. 50:2001;2438-2443
222. Kamegai J., Wakabayashi I., Miyamoto K., Unterman T.G., Kineman R.D., Frohman L.A. Growth hormone-dependent regulation of pituitary GH secretagogue receptor (GHS-R) mRNA levels in the spontaneous dwarf rat. Neuroendocrinology. 68:1998;312-318
223. Kanamoto N., Akamizu T., Hosoda H., Hataya Y., Ariyasu H., Takaya K., Hosoda K., Saijo M., Moriyama K., Shimatsu A., Kojima M., Kangawa K., Nakao K. Substantial production of ghrelin by a human medullary thyroid carcinoma cell line. J. Clin. Endocrinol. Metab. 86:2001;4984-4990
224. Kasayama S., Otsuki M., Takagi M., Saito H., Sumitani S., Kouhara H., Koga M., Saitoh Y., Ohnishi T., Arita N. Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin. Endocrinol. (Oxf.). 52:2000;549-555
225. H. Katakami, S. Hashida, T. Usui, S.Matsukura. Role of endogenous ghrelin in the control of GH secretion in conscious rats, in: Proceedings of the 84th Annual Meeting of the Endocrine Society, P2-110, 2002
226. Katayama M., Nogami H., Nishiyama J., Kawase T., Kawamura K. Developmentally and regionally regulated expression of growth hormone secretagogue receptor mRNA in rat brain and pituitary gland. Neuroendocrinology. 72:2000;333-340
227. + concentration of rat pituitary cells in primary culture. J. Neuroendocrinol. 11:1999;795-800
228. Katugampola S.D., Kuc R.E., Maguire J.J., Davenport A.P. G-protein-coupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de- orphanized (urotensin-II, apelin and ghrelin) receptors. Clin. Sci. Lond. 103(Suppl. 1):2002;171S-175S
229. 125I-His(9)]- Ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br. J. Pharmacol. 134:2001;143-149
230. Kawabe J., Iwami G., Ebina T., Ohno S., Katada T., Ueda Y., Homcy C.J., Ishikawa Y. Differential activation of adenylyl cyclase by protein kinase C isoenzymes [published erratum appears in J. Biol. Chem. 269 (36) (1994) 22912]. J. Biol. Chem. 269:1994;16554-16558
231. Kim M.S., Small C.J., Stanley S.A., Morgan D.G., Seal L.J., Kong W.M., Edwards C.M., Abusnana S., Sunter D., Ghatei M.A., Bloom S.R. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J. Clin. Invest. 105:2000;1005-1011
232. Kim M.S., Yoon C.Y., Park K.H., Shin C.S., Park K.S., Kim S.Y., Cho B.Y., Lee H.K. Changes in ghrelin and ghrelin receptor expression according to feeding status. NeuroReport. 14:2003;1317-1320
233. Kineman R.D., Kamegai J., Frohman L.A. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692, 585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels. Endocrinology. 140:1999;3581-3586
234. King M.K., Gay D.M., Pan L.C., McElmurray J.H., Hendrick J.W., Pirie C., Morrison A., Ding C., Mukherjee R., Spinale F.G. Treatment with a growth hormone secretagogue in a model of developing heart failure - Effects on ventricular and myocyte function. Circulation. 103:2001;308-313
235. Kishimoto M., Okimura Y., Nakata H., Kudo T., Iguchi G., Takahashi Y., Kaji H., Chihara K. Cloning and characterization of the 5 (')-flanking region of the human ghrelin gene. Biochem. Biophys. Res. Commun. 305:2003;186-192
236. Kitamura S., Yokota I., Hosoda H., Kotani Y., Matsuda J., Naito E., Ito M., Kangawa K., Kuroda Y. Ghrelin concentration in cord and neonatal blood: relation to fetal growth and energy balance. J. Clin. Endocrinol. Metab. 88:2003;5473-5477
237. Klinger B., Sibergeld A., Deghenghi R., Frenkel J., Laron Z. Desensitization from long-term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormone-releasing peptide in short children. Eur. J. Endocrinol. 134:1996;716-719
238. Knerr I., Groschl M., Rascher W., Rauh M. Endocrine effects of food intake: insulin, ghrelin, and leptin responses to a single bolus of essential amino acids in humans. Ann. Nutr. Metab. 47:2003;312-318
239. Kohno D., Gao H.Z., Muroya S., Kikuyama S., Yada T. Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca(2+) signaling via protein kinase a and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes. 52:2003;948-956
240. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:1999;656-660
241. Kojima M., Haruno R., Nakazato M., Date Y., Murakami N., Hanada R., Matsuo H., Kangawa K. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). Biochem. Biophys. Res. Commun. 276:2000;435-438
242. Koo G.C., Huang C., Camacho R., Trainor C., Blake J.T., Sirotina-Meisher A., Schleim K.D., Wu T.J., Cheng K., Nargund R., McKissick G. Immune enhancing effect of a growth hormone secretagogue. J. Immunol. 166:2001;4195-4201
243. Korbonits M., Adams E.F., Grossman A.B. The effects of GH-secretagogues on human pituitary cells in culture and on rat hypothalamic tissue. Dieguez C., Ghigo E., Boghen M.F., Casanueva F.F. Growth Hormone Secretagogues: Basic Findings and Clinical Implications. 1999;65-77 Elsevier, Amsterdam
244. Korbonits M., Bustin S.A., Kojima M., Jordan S., Adams E.F., Lowe D.G., Kangawa K., Grossman A.B. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J. Clin. Endocrinol. Metab. 86:2001;881-887
245. Korbonits M., Grossman A.B. Growth hormone-releasing peptide and its analogues; novel stimuli to growth hormone release. Trends Endocrinol. Metab. 6:1995;43-49
246. Korbonits M., Gueorguiev M., O'Grady E., Lecoeur C., Swan D.C., Mein C.A., Weill J., Grossman A.B., Froguel P. A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J. Clin. Endocrinol. Metab. 87:2002;4005-4008
247. Korbonits M., Jacobs R.A., Aylwin S.J.B., Burrin J.M., Dahia P.L.M., Monson J.P., Trainer P.J., Chew S.L., Besser G.M., Grossman A.B. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. J. Clin. Endocrinol. Metab. 83:1998;3624-3630
248. Korbonits M., Kojima M., Kangawa K., Grossman A.B. Presence of ghrelin in normal and adenomatous human pituitary. Endocrine. 14:2001;101-104
249. Korbonits M., Kaltsas G., Perry L.A., Grossman A.B., Monson J.P., Besser G.M., Trainer P.J. Hexarelin as a test of pituitary reserve in patients with pituitary disease. Clin. Endocrinol. (Oxf.). 51:1999;369-375
250. Korbonits M., Kaltsas G., Perry L.A., Putignano P., Grossman A.B., Besser G.M., Trainer P.J. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J. Clin. Endocrinol. Metab. 84:1999;2489-2495
251. Korbonits M., Little J.A., Forsling M.L., Tringali G., Costa A., Navarra P., Trainer P.J., Grossman A.B. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. J. Neuroendocrinol. 11:1999;521-528
252. Korbonits M., Trainer P.J., Besser G.M. The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clin. Endocrinol. (Oxf.). 43:1995;365-371
253. Koutkia P., Meininger G., Canavan B., Breu J., Grinspoon S. Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy. Am. J. Physiol. Endocrinol. Metab. 286:2004;E296-E303
254. Kovacs M., Kineman R.D., Schally A.V., Flerko B., Frohman L.A. Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment. J. Neuroendocrinol. 12:2000;335-341
255. Krsek M., Rosicka M., Haluzik M., Svobodova J., Kotrlikova E., Justova V., Lacinova Z., Jarkovska Z. Plasma ghrelin levels in patients with short bowel syndrome. Endocr. Res. 28:2002;27-33
256. Krsek M., Rosicka M., Papezova H., Krizova J., Kotrlikova E., Haluz'k M., Justova V., Lacinova Z., Jarkovska Z. Plasma ghrelin levels and malnutrition: a comparison of two etiologies. Eat. Weight. Disord. 8:2003;207-211
257. Kuriyama H., Hotta M., Wakabayashi I., Shibasaki T. A 6-day intracerebroventricular infusion of the growth hormone- releasing peptide KP-102 stimulates food intake in both nonstressed and intermittently-stressed rats. Neurosci. Lett. 282:2000;109-112
258. Lall S., Tung L.Y.C., Ohlsson C., Jansson J.O., Dickson S.L. Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochem. Biophys. Res. Commun. 280:2001;132-138
259. Larsson B., Norlen P., Lindstrom E., Zhao D., Hakanson R., Linde A. Effects of ECL cell extracts and granule/vesicle-enriched fractions from rat oxyntic mucosa on cAMP and IP(3) in rat osteoblast-like cells. Regul. Pept. 106:2002;13-18
260. Laron Z., Frenkel J., Deghenghi R., Anin S., Klinger B., Silbergeld A. Intranasal administration of the GHRP hexarelin accelerates growth in short children. Clin. Endocrinol. (Oxf.). 43:1995;631-635
261. Laron Z., Frenkel J., Gil-Ad I., Klinger B., Lubin E., Wuthrich P., Boutignon F., Lengerts V., Deghenghi R. Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin). Clin. Endocrinol. (Oxf.). 41:1994;539-541
262. Lawrence C.B., Snape A.C., Baudoin F.M., Luckman S.M. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology. 143:2002;155-162
263. Leal-Cerro A., Pumar A., Garcia-Garcia E., Dieguez C., Casanueva F.F. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome. Clin. Endocrinol. (Oxf.). 41:1994;649-654
264. Leal-Cerro A., Torres E., Soto A., Dios E., Deghenghi R., Arvat E., Ghigo E., Dieguez C., Casanueva F.F. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses. Neuroendocrinology. 76:2002;390-396
265. Lee H.M., Wang G., Englander E.W., Kojima M., Greeley J.G. Jr. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology. 143:2002;185-190
266. Lehto-Axtelius D., Chen D., Surve V.V., Hakanson R. Post-gastrectomy osteopenia in the rat: bone structure is preserved by retaining 10-30% of the oxyntic gland area. Scand. J. Gastroenterol. 37:2002;437-443
267. Lei T., Buchfelder M., Fahlbush R., Adams E.F. Growth hormone-releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells. J. Mol. Endocrinol. 14:1995;135-138
268. Leonetti F., Silecchia G., Iacobellis G., Ribaudo M.C., Zappaterreno A., Tiberti C., Iannucci C.V., Perrotta N., Bacci V., Basso M.S., Basso N., Di Mario U. Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J. Clin. Endocrinol. Metab. 88:2003;4227-4231
269. Lieber R.L., Jacks T.M., Mohler R.L., Schleim K., Haven M., Cuizon D., Gershuni D.H., Lopez M.A., Hora D., Nargund R., Feeney W., Hickey G.J. Growth hormone secretagogue increases muscle strength during remobilization after canine hindlimb immobilization. J. Orthopaed. Res. 15:1997;519-527
270. Lin Y., Matsumura K., Fukuhara M., Kagiyama S., Fujii K., Iida M. Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension. 2004
271. Lin L., Martin R., Schaffhauser A.O., York D.A. Acute changes in the response to peripheral leptin with alteration in the diet composition. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280:2001;R504-R509
272. Lindeman J.H., Pijl H., Van Dielen F.M., Lentjes E.G., Van Leuven C., Kooistra T. Ghrelin and the hyposomatotropism of obesity. Obes. Res. 10:2002;1161-1166
273. Liu Y.L., Yakar S., Otero-Corchon V., Low M.J., Liu J.L. Ghrelin gene expression is age-dependent and influenced by gender and the level of circulating IGF-I. Mol. Cell. Endocrinol. 189:2002;97-103
274. Locatelli V., Grilli R., Torsello A., Cella S.G., Wehrenberg W.B., Müller E.E. Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat. Pediatr. Res. 36:1994;169-174
275. Locatelli V., Rossoni G., Schweiger F., Torsello A., De Gennaro Colonna V., Bernareggi M., Deghenghi R., Muller E.E., Berti F. Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology. 140:1999;4024-4031
276. Loche S., Cambiaso P., Carta D., Setzu S., Imbimbo B.P., Borrelli P., Pintor C., Cappa M. The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects. J. Clin. Endocrinol. Metab. 80:1995;674-678
277. Locke W., Kirgis H.D., Bowers C.Y., Abdoh A.A. Intracerebroventricular growth-hormone-releasing peptide-6 stimulates eating without affecting plasma growth-hormone responses in rats. Life Sci. 56:1995;1347-1352
278. Lucidi P., Murdolo G., DiLoreto C., De Cicco A., Parlanti N., Fanelli C., Santeusanio F., Bolli G.B., De Feo P. Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia. Diabetes. 51:2002;2911-2914
279. Maheshwari H.G., Rahim A., Shalet S.M., Baumann G. Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency. J. Clin. Endocrinol. Metab. 84:1999;956-959
280. Makino Y., Hosoda H., Shibata K., Makino I., Kojima M., Kangawa K., Kawarabayashi T. Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy. Hypertension. 39:2002;781-784
281. Malagon M.M., Luque R.M., Ruiz-Guerrero E., Rodriguez-Pacheco F., Garcia-Navarro S., Casanueva F.F., Gracia-Navarro F., Castano J.P. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes. Endocrinology. 2003
282. 2 (GHRP-6)-induced GH secretion in the rat. Neuroendocrinology. 57:1993;247-256
283. Marchesini G., Pagotto U., Bugianesi E., De Iasio R., Manini R., Vanni E., Pasquali R., Melchionda N., Rizzetto M. Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. J. Clin. Endocrinol. Metab. 88:2003;5674-5679
284. Masaoka T., Suzuki H., Hosoda H., Ota T., Minegishi Y., Nagata H., Kangawa K., Ishii H. Enhanced plasma ghrelin levels in rats with streptozotocin-induced diabetes. FEBS Lett. 541:2003;64-68
285. Masuda Y., Tanaka T., Inomata N., Ohnuma N., Tanaka S., Itoh Z., Hosoda H., Kojima M., Kangawa K. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem. Biophys. Res. Commun. 276:2000;905-908
286. Matsumura K., Tsuchihashi T., Fujii K., Abe I., Iida M. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension. 40:2002;694-699
287. Matsumura K., Tsuchihashi T., Fujii K., Iida M. Neural regulation of blood pressure by leptin and the related peptides. Regul. Pept. 114:2003;79-86
288. McCowen K.C., Maykel J.A., Bistrian B.R., Ling P.R. Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents. J. Endocrinol. 175:2002;R7-R11
289. McKee K.K., Palyha O.C., Feighner S.D., Hreniuk D.L., Tan C.P., Phillips M.S., Smith R.G., Van der Ploeg L.H.T., Howard A.D. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol. Endocrinol. 11:1997;415-423
290. McKee K.K., Tan C.P., Palyha O.C., Liu J., Feighner S.D., Hreniuk D.L., Smith R.G., Howard A.D., Van der Ploeg L.H.T. Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics. 46:1997;426-434
291. Mericq V., Cassorla F., Bowers C.Y., Avila A., Gonen B., Merriam G.R. Changes in appetite and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in growth hormone deficient children. J. Pediatr. Endocrinol. Metab. 16:2003;981-985
292. Mericq V., Cassorla F., Salazar T., Avila A., Iniguez G., Bowers C.Y., Merriam G.R. Effects of eight months treatment with graded doses of a growth hormone (GH)-releasing peptide in GH-deficient children. J. Clin. Endocrinol. Metab. 83:1998;2355-2360
293. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferre P., Birnbaum M.J., Stuck B.J., Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature. 2004
294. Minokoshi Y., Kim Y.B., Peroni O.D., Fryer L.G., Muller C., Carling D., Kahn B.B. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 415:2002;339-343
295. Monteleone P., Bencivenga R., Longobardi N., Serritella C., Maj M. Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women. J. Clin. Endocrinol. Metab. 88:2003;5510-5514
296. Mori K., Yoshimoto A., Takaya K., Hosoda K., Ariyasu H., Yahata K., Mukoyama M., Sugawara A., Hosoda H., Kojima M., Kangawa K., Nakao K. Kidney produces a novel acylated peptide, ghrelin. FEBS Lett. 486:2000;213-216
297. Morley J.E., Alshaher M.M., Farr S.A., Flood J.F., Kumar V.B. Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: further evidence for a role of nitric oxide in feeding. Peptides. 20:1999;595-600
298. Mozid A.M., Tringali G., Forsling M.L., Hendricks M.S., Ajodha S., Edwards R., Navarra P., Grossman A.B., Korbonits M. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm. Metab. Res. 35:2003;455-459
299. Muccioli G., Broglio F., Valetto M.R., Ghe C., Catapano F., Graziani A., Papotti M., Bisi G., Deghenghi R., Ghigo E. Growth hormone-releasing peptides and the cardiovascular system. Ann. Endocrinol. 61:2000;27-31
300. Muccioli G., Ghe C., Ghigo M.C., Papotti M., Arvat E., Boghen M.F., Nilsson M.H.L., Deghenghi R., Ong H., Ghigo E. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J. Endocrinol. 157:1998;99-106
301. 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J. Endocrinol. Invest. 24:2001;RC7-RC9
302. Muller A.F., Janssen J.A., Hofland L.J., Lamberts S.W., Bidlingmaier M., Strasburger C.J., Der Lely A.J.A. Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance. J. Clin. Endocrinol. Metab. 86:2001;590-593
303. Muller A.F., Lamberts S.W., Janssen J.A., Hofland L.J., Koetsveld P.V., Bidlingmaier M., Strasburger C.J., Ghigo E., van der Lely A.J. Ghrelin drives GH secretion during fasting in man. Eur. J. Endocrinol. 146:2002;203-207
304. Murakami N., Hayashida T., Kuroiwa T., Nakahara K., Ida T., Mondal M.S., Nakazato M., Kojima M., Kangawa K. Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats. J. Endocrinol. 174:2002;283-288
305. Murata M., Okimura Y., Iida K., Matsumoto M., Sowa H., Kaji H., Kojima M., Kangawa K., Chihara K. Ghrelin modulates the downstream of insulin signaling in hepatoma cells. J. Biol. Chem. 277:2002;5667-5674
306. Murdolo G., Lucidi P., Di Loreto C., Parlanti N., De Cicco A., Fanelli C., Perriello G., Mughetti D., Pippi R., Brozzetti A., Santeusanio F., De Feo P. Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement. J. Endocrinol. Invest. 26:2003;244-249
307. Murphy M.G., Bach M.A., Plotkin D., Bolognese J.A., Ng J., Krupa D., Cerchio K., Gertz B.J. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. J. Bone Miner. Res. 14:1999;1182-1188
308. Murphy M.G., Weiss S., McClung M., Schnitzer T., Cerchio K., Connor J., Krupa D., Gertz B.J. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. J. Clin. Endocrinol. Metab. 86:2001;1116-1125
309. Mustonen A.M., Nieminen P., Hyvarinen H. Preliminary evidence that pharmacologic melatonin treatment decreases rat ghrelin levels. Endocrine. 16:2001;43-46
310. Nagamine J., Nagata R., Seki H., Nomura-Akimaru N., Ueki Y., Kumagai K., Taiji M., Noguchi H. Pharmacological profile of a new orally active growth hormone secretagogue, SM-130686. J. Endocrinol. 171:2001;481-489
311. Nagaya N., Kangawa K. Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr. Opin. Pharmacol. 3:2003;146-151
312. Nagaya N., Kangawa K. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure. Regul. Pept. 114:2003;71-77
313. Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., Hayashi Y., Kangawa K. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280:2001;R1483-R1487
314. Nagaya N., Miyatake K., Uematsu M., Oya H., Shimizu W., Hosoda H., Kojima M., Nakanishi N., Mori H., Kangawa K. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J. Clin. Endocrinol. Metab. 86:2001;5854-5859
315. Nagaya N., Uematsu M., Kojima M., Date Y., Nakazato M., Okumura H., Hosoda H., Shimizu W., Yamagishi M., Oya H., Koh H., Yutani C., Kangawa K. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation. 104:2001;2034-2038
316. Nagaya N., Uematsu M., Kojima M., Ikeda Y., Yoshihara F., Shimizu W., Hosoda H., Hirota Y., Ishida H., Mori H., Kangawa K. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation. 104:2001;1430-1435
317. Nakagawa E., Nagaya N., Okumura H., Enomoto M., Oya H., Ono F., Hosoda H., Kojima M., Kangawa K. Hyperglycaemia suppresses the secretion of ghrelin, a novel growth- hormone-releasing peptide: responses to the intravenous and oral administration of glucose. Clin. Sci. (Lond.). 103:2002;325-328
318. Nakai Y., Hosoda H., Nin K., Ooya C., Hayashi H., Akamizu T., Kangawa K. Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa. Eur. J. Endocrinol. 149:2003;R001-R003
319. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S. A role for ghrelin in the central regulation of feeding. Nature. 409:2001;194-198
320. A.M. Nanzer, A.M. Mozid, R.C. Fowkes, S. Khalaf, M.V. Patel, J.M. Burrin, A.B. Grossman, M. Korbonits, Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase (MAPK) pathway, Eur. J. Endocrinol. (2004) (in press)
321. Nargund R.P., Van der Ploeg L.H.T. Growth hormone secretagogues. Bristol J.A. Annual Reports in Medicinal Chemistry. vol. 32:1997;221-230 Academic Press, New York
322. Nass R., Gilrain J., Anderson S., Gaylinn B., Dalkin A., Day R., Peruggia M., Thorner M.O. High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in rat pituitary. Endocrinology. 141:2000;2084-2089
323. Nedvidkova J., Krykorkova I., Bartak I.V., Papezova H., Gold P.W., Alesci S., Pacak K. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 88:2003;1678-1682
324. Nwokolo C.U., Freshwater D.A., O'Hare P., Randeva H.S. Plasma ghrelin following cure of Helicobacter pylori. Gut. 52:2003;637-640
325. Obal F. Jr., Alt J., Taishi P., Gardi J., Krueger J.M. Sleep in mice with nonfunctional growth hormone-releasing hormone receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284:2003;R131-R139
326. Okada K., Ishii S., Minami S., Sugihara H., Shibasaki T., Wakabayashi I. Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats. Endocrinology. 137:1996;5155-5158
327. Okimura Y., Ukai K., Hosoda H., Murata M., Iguchi G., Iida K., Kaji H., Kojima M., Kangawa K., Chihara K. The role of circulating ghrelin in growth hormone (GH) secretion in freely moving male rats. Life Sci. 72:2003;2517-2524
328. Okumura H., Nagaya N., Enomoto M., Nakagawa E., Oya H., Kangawa K. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J. Cardiovasc. Pharmacol. 39:2002;779-783
329. Olson G.A., Olson R.D., Kastin A.J., Coy D.H. Endogenous opiates: through 1978. Neurosci. Biobehav. Rev. 3:1979;285-299
330. Olszewski P.K., Grace M.K., Billington C.J., Levine A.S. Hypothalamic paraventricular injections of ghrelin: effect on feeding and c-Fos immunoreactivity. Peptides. 24:2003;919-923
331. Olszewski P.K., Li D., Grace M.K., Billington C.J., Kotz C.M., Levine A.S. Neural basis of orexigenic effects of ghrelin acting within lateral hypothalamus. Peptides. 24:2003;597-602
332. Ong H., Bodart V., McNicoll N., Lamontagne D., Bouchard J.F. Identification and characterization of a new GHRP receptor in the heart. Growth Horm. IGF Res. 8:1998;137-140
333. Ong H., McNicoll N., Escher E., Collu R., Deghenghi R., Locatelli V., Ghigo E., Muccioli G., Boghen M.F., Nilsson M. Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling. Endocrinology. 139:1998;432-435
334. Orio F. Jr., Lucidi P., Palomba S., Tauchmanova L., Cascella T., Russo T., Zullo F., Colao A., Lombardi G., De Feo P. Circulating ghrelin concentrations in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88:2003;942-945
335. Orkin R.D., New D.I., Norman D., Chew S.L., Clark A.J.L., Grossman A.B., Korbonits M. Rapid desensitisation of the growth hormone secretagogue (ghrelin) receptor to hexarelin in vitro. J. Endocrinol. Invest. 26:2003;743-747
336. Ostergard T., Hansen T.K., Nyholm B., Gravholt C.H., Djurhuus C.B., Hosoda H., Kangawa K., Schmitz O. Circulating ghrelin concentrations are reduced in healthy offspring of Type 2 diabetic subjects, and are increased in women independent of a family history of Type 2 diabetes. Diabetologia. 46:2003;134-136
337. Ott V., Fasshauer M., Dalski A., Meier B., Perwitz N., Klein H.H., Tschop M., Klein J. Direct peripheral effects of ghrelin include suppression of adiponectin expression. Horm. Metab. Res. 34:2002;640-645
338. Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R.L., Heiman M.L., Lehnert P., Fichter M., Tschöp M. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur. J. Endocrinol. 145:2001;669-673
339. Pagotto U., Gambineri A., Pelusi C., Genghini S., Cacciari M., Otto B., Castaneda T., Tschop M., Pasquali R. Testosterone replacement therapy restores normal ghrelin in hypogonadal men. J. Clin. Endocrinol. Metab. 88:2003;4139-4143
340. Pagotto U., Gambineri A., Vicennati V., Heiman M.L., Tschöp M., Pasquali R. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. J. Clin. Endocrinol. Metab. 87:2002;5625-5629
341. Palyha O.C., Feighner S.D., Tan C.P., McKee K.K., Hreniuk D.L., Gao Y.-D., Schleim K.D., Yang L., Morriello G., Nargund R., Patchett A.A., Howard A.D., Smith R.G. Ligand activation domain of human orphan growth hormone (GH) secretagogue receptor (GHS-R) conserved from pufferfish to humans. Mol. Endocrinol. 14:2000;160-169
342. Pan L.C., Carpino P.A., Lefker B.A., Ragan J.A., Toler S.M., Pettersen J.C., Nettleton D.O., Ng O., Pirie C.M., Chidsey-Frink K., Lu B., Nickerson D.F., Tess D.A., Mullins M.A., MacLean D.B., DaSilva-Jardine P.A., Thompson D.D. Preclinical pharmacology of CP-424, 391, an orally active pyrazolinone- piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue. Endocrine. 14:2001;121-132
343. Pandya N., DeMottFriberg R., Bowers C.Y., Barkan A.L., Jaffe C.A. Growth hormone (GH) releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation. J. Clin. Endocrinol. Metab. 83:1998;1186-1189
344. Papotti M., Cassoni P., Volante M., Deghenghi R., Muccioli G., Ghigo E. Ghrelin-producing endocrine tumors of the stomach and intestine. J. Clin. Endocrinol. Metab. 86:2001;5052-5059
345. Papotti M., Ghe C., Cassoni P., Catapano F., Deghenghi R., Ghigo E., Muccioli G. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab. 85:2000;3803-3807
346. Parhar I.S., Sato H., Sakuma Y. Ghrelin gene in cichlid fish is modulated by sex and development. Biochem. Biophys. Res. Commun. 305:2003;169-175
347. Pemberton C., Wimalasena P., Yandle T., Soule S., Richards M. C-terminal pro-ghrelin peptides are present in the human circulation. Biochem. Biophys. Res. Commun. 310:2003;567-573
348. Penalva A., Pombo M., Carballo A., Barreiro J., Casanueva F.F., Dieguez C. Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6. Clin. Endocrinol. (Oxf.). 38:1993;87-91
349. Peng X., Park S., Gadelha M.R., Coschigano K.T., Kopchick J.J., Frohman L.A., Kineman R.D. The growth hormone (GH)-axis of GH receptor/binding protein gene- disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback. Endocrinology. 142:2001;1117-1123
350. Petersenn S., Rasch A.C., Penshorn M., Beil F.U., Schulte H.M. Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor. Endocrinology. 142:2001;2649-2659
351. Pettersson I., Muccioli G., Granata R., Deghenghi R., Ghigo E., Ohlsson C., Isgaard J. Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation. J. Endocrinol. 175:2002;201-209
352. Phung L.T., Inoue H., Nou V., Lee H.G., Vega R.A., Matsunaga N., Hidaka S., Kuwayama H., Hidari H. The effects of growth hormone-releasing peptide-2 (GHRP-2) on the release of growth hormone and growth performance in swine. Domest. Anim. Endocrinol. 18:2000;279-291
353. Pierno S., De Luca A., Desaphy J.F., Fraysse B., Liantonio A., Didonna M.P., Lograno M., Cocchi D., Smith R.G., Camerino D.C. Growth hormone secretagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor. Br. J. Pharmacol. 139:2003;575-584
354. Pihoker C., Badger T.M., Reynolds G.A., Bowers C.Y. Treatment effects of intranasal growth hormone releasing peptide- 2 in children with short stature. J. Endocrinol. 155:1997;79-86
355. Pinilla L., Barreiro M.L., Tena-Sempere M., Aguilar E. Role of ghrelin in the control of growth hormone secretion in prepubertal rats: interactions with excitatory amino acids. Neuroendocrinology. 77:2003;83-90
356. Pombo M., Barreiro J., Penalva A., Peino R., Dieguez C., Casanueva F.F. Absence of growth-hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary-stalk transection. J. Clin. Endocrinol. Metab. 80:1995;3180-3184
357. Pomes A., Pong S.S., Schaeffer J.M. Solubilization and characterization of a growth hormone secretagogue receptor from porcine anterior pituitary membranes. Biochem. Biophys. Res. Commun. 225:1996;939-945
358. Pong S.S., Chaung L.-Y.P., Dean C.D., Nargund R.P., Patchett A.A., Smith R.G. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol. Endocrinol. 10:1996;57-61
359. Popovic V., Damjanovic S., Micic D., Djurovic M., Dieguez C., Casanueva F.F. Blocked growth hormone-releasing peptide (GHRP-6)-induced growth hormone secretion and absence of the synergic action of GHRP-6 plus growth hormone-releasing hormone in patients with hypothalamopituitary disconnection - evidence that GHRP-6 main action is exerted at the hypothalamic level. J. Clin. Endocrinol. Metab. 80:1995;942-947
360. Popovic V., Leal A., Micic D., Koppeschaar H.P.F., Torres E., Paramo C., Obradovic S., Dieguez C., Casanueva F.F. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet. 356:2000;1137-1142
361. Popovic V., Miljic D., Micic D., Damjanovic S., Arvat E., Ghigo E., Dieguez C., Casanueva F.F. Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. J. Clin. Endocrinol. Metab. 88:2003;3450-3453
362. Pöykkö S.M., Kellokoski E., Horkko S., Kauma H., Kesaniemi Y.A., Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes. 52:2003;2546-2553
363. Pöykkö S.M., Ukkola O., Kauma H., Savolainen M.J., Kesäniemi Y.A. Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects. Diabetologia. 46:2003;455-458
364. Prado C.L., Pugh-Bernard A.E., Elghazi L., Sosa-Pineda B., Sussel L. Ghrelin cells replace insulin-producing {beta}cells in two mouse models of pancreas development. Proc. Natl. Acad. Sci. USA. 101:2004;2924-2929
365. Purnell J.Q., Weigle D.S., Breen P.A., Cummings D.E. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J. Clin. Endocrinol. Metab. 88:2003;5747-5752
366. Qian S., Chen H., Weingarth D., Trumbauer M.E., Novi D.E., Guan X., Yu H., Shen Z., Feng Y., Frazier E., Chen A., Camacho R.E., Shearman L.P., Gopal-Truter S., MacNeil D.J., Van der Ploeg L.H.T., Marsh D.J. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol. Cell. Biol. 22:2002;5027-5035
367. Rahim A., O'Neill P.A., Shalet S.M. The effect of chronic hexarelin administration on the pituitary-adrenal axis and prolactin. Clin. Endocrinol. (Oxf.). 50:1999;77-84
368. Raun K., Sehested Hansen B., Johansen N.L., Togersen H., Madsen K., Ankersen M., Andersen P.H. Ipamorelin, the first selective growth hormone secretagogue. Eur. J. Endocrinol. 139:1998;552-561
369. Ravussin E., Tschöp M., Morales S., Bouchard C., Heiman M.L. Plasma ghrelin concentration and energy balance: overfeeding and negative energy balance studies in twins. J. Clin. Endocrinol. Metab. 86:2001;4547
370. Reimer M.K., Pacini G., Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology. 144:2003;916-921
371. Riediger T., Traebert M., Schmid H.A., Scheel C., Lutz T.A., Scharrer E. Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus. Neurosci. Lett. 341:2003;151-155
372. Rigamonti A.E., Pincelli A.I., Corra B., Viarengo R., Bonomo S.M., Galimberti D., Scacchi M., Scarpini E., Cavagnini F., Muller E.E. Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. J. Endocrinol. 175:2002;R1-R5
373. Riis A.L., Hansen T.K., Moller N., Weeke J., Jorgensen J.O. Hyperthyroidism is associated with suppressed circulating ghrelin levels. J. Clin. Endocrinol. Metab. 88:2003;853-857
374. Rindi G., Savio A., Torsello A., Zoli M., Locatelli V., Cocchi D., Paolotti D., Solcia E. Ghrelin expression in gut endocrine growths. Histochem. Cell Biol. 117:2002;521-525
375. Ronchi C., Epaminonda P., Cappiello V., Beck-Peccoz P., Arosio M. Effects of two different somatostatin analogs on glucose tolerance in acromegaly. J. Endocrinol. Invest. 25:2002;502-507
376. Rossoni G., Locatelli V., Colonna V.D., Muller E.E., Berti F. Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium- free medium. Pharmacol. Res. 42:2000;129-136
377. Ruter J., Kobelt P., Tebbe J.J., Avsar Y.Y., Veh R., Wang L., Klapp B.F., Wiedenmann B., Tache Y., Monnikes H. Intraperitoneal injection of ghrelin induces Fos expression in the paraventricular nucleus of the hypothalamus in rats. Brain Res. 991:2003;26-33
378. Saad M.F., Bernaba B., Hwu C.M., Jinagouda S., Fahmi S., Kogosov E., Boyadjian R. Insulin regulates plasma ghrelin concentration. J. Clin. Endocrinol. Metab. 87:2002;3997-4000
379. Saito E.S., Kaiya H., Takagi T., Yamasaki I., Denbow D.M., Kangawa K., Furuse M. Chicken ghrelin and growth hormone-releasing peptide-2 inhibit food intake of neonatal chicks. Eur. J. Pharmacol. 453:2002;75-79
380. Sakata I., Nakamura K., Yamazaki M., Matsubara M., Hayashi Y., Kangawa K., Sakai T. Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. Peptides. 23:2002;531-536
381. Sakata I., Tanaka T., Matsubara M., Yamazaki M., Tani S., Hayashi Y., Kangawa K., Sakai T. Postnatal changes in ghrelin mRNA expression and in ghrelin-producing cells in the rat stomach. J. Endocrinol. 174:2002;463-471
382. Sakata I., Yamazaki M., Inoue K., Hayashi Y., Kangawa K., Sakai T. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci. Lett. 342:2003;183-186
383. M. Samia, Q. Chen, C.Y. Bowers, G.S. Tannenbaum, Gender-related differences in ghrelins stimulatory actions on pulsatile growth hormone secretion and feeding behavior, in: Proceedings of the 85th Annual Meeting of the Endocrine Society, P2-219, 2003
384. Samson W.K., Lumpkin M.D., Nilaver G., McCann S.M. Motilin: a novel growth hormone releasing agent. Brain Res. Bull. 12:1984;57-62
385. 2 in the rat. Endocrinology. 117:1985;1441-1447
386. Schaller G., Schmidt A., Pleiner J., Woloszczuk W., Wolzt M., Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes. 52:2003;16-20
387. Schoen W.R., Pisano J.M., Pendregrats K., Wyvratt M.J. Jr., Fisher M.H., Cheng K., Chan W.W.S., Butler B., Smith R.G., Ball R.G. A novel 3-substituted benzazepinone growth hormone secretagogue (L-692, 429). J. Med. Chem. 37:1994;897-906
388. Schöfl C., Horn R., Schill T., Schlosser H.W., Muller M.J., Brabant G. Circulating ghrelin levels in patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87:2002;4607-4610
389. Schwartz G.J., Moran T.H., White W.O., Ladenheim E.E. Relationships between gastric motility and gastric vagal afferent responses to CCK and GRP in rats differ. Am. J Physiol. 272:1997;R1726-R1733
390. Seoane L.M., Tovar S., Baldelli R., Arvat E., Ghigo E., Casanueva F.F., Dieguez C. Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. Eur. J. Endocrinol. 143:2000;R7-R9
391. Senti M., Tomas M., Fito M., Weinbrenner T., Covas M.I., Sala J., Masia R., Marrugat J. Antioxidant paraoxonase 1 activity in the metabolic syndrome. J. Clin. Endocrinol. Metab. 88:2003;5422-5426
392. Sethumadhavan K., Veeraragavan K., Bowers C.Y. Demonstration and characterization of the specific binding of growth hormone-releasing peptide to rat anterior pituitary and hypothalamic membranes. Biochem. Biophys. Res. Commun. 178:1991;31-37
393. Shah N., Evans W.S., Bowers C.Y., Veldhuis J.D. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-h GH-releasing peptide infusion: Pulsatile, entropic, and nyctohemeral mechanisms. J. Clin. Endocrinol. Metab. 84:1999;2140-2150
394. Shah N., Evans W.S., Bowers C.Y., Veldhuis J.D. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women. J. Clin. Endocrinol. Metab. 85:2000;2649-2659
395. Shibasaki T., Yamauchi N., Takeuchi K., Ishii S., Sugihara H., Wakabayashi I. The growth hormone secretagogue KP-102-induced stimulation of food intake is modified by fasting, restraint stress, and somatostatin in rats. Neurosci. Lett. 255:1998;9-12
396. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., Nozoe S., Hosoda H., Kangawa K., Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab. 87:2002;240-244
397. Shimizu Y., Nagaya N., Isobe T., Imazu M., Okumura H., Hosoda H., Kojima M., Kangawa K., Kohno N. Increased plasma ghrelin level in lung cancer cachexia. Clin. Cancer Res. 9:2003;774-778
398. Shimizu Y., Nagaya N., Teranishi Y., Imazu M., Yamamoto H., Shokawa T., Kangawa K., Kohno N., Yoshizumi M. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem. Biophys. Res. Commun. 310:2003;830-835
399. Shintani M., Ogawa Y., Ebihara K., Aizawa-Abe M., Miyanaga F., Takaya K., Hayashi T., Inoue G., Hosoda K., Kojima M., Kangawa K., Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes. 50:2001;227-232
400. Shuto Y., Shibasaki T., Otagiri A., Kuriyama H., Ohata H., Tamura H., Kamegai J., Sugihara H., Oikawa S., Wakabayashi I. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J. Clin. Invest. 109:2002;1429-1436
401. Shuto Y., Shibasaki T., Wada K., Parhar I., Kamegai J., Sugihara H., Oikawa S., Wakabayashi I. Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats. Life Sci. 68:2001;991-996
402. Sibilia V., Cocchi D., Pagani F., Lattuada N., Moro G.L., Pecile A., Rubinacci A., Muller E.E., Netti C. Hexarelin, a growth hormone-releasing peptide, counteracts bone loss in gonadectomized male rats. Growth Horm. IGF Res. 9:1999;219-227
403. Sibilia V., Pagani F., Guidobono F., Locatelli V., Torsello A., Deghenghi R., Netti C. Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats. Neuroendocrinology. 75:2002;92-97
404. Sibilia V., Rindi G., Pagani F., Rapetti D., Locatelli V., Torsello A., Campanini N., Deghenghi R., Netti C. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology. 144:2003;353-359
405. Smith R.G., Griffin P.R., Xu Y., Smith A.G.A., Liu K., Calacay J., Feighner S.D., Pong S.S., Leong D., Pomes A., Cheng K., Van der Ploeg L.H.T., Howard A.D., Schaeffer J.M., Leonard R.J. Adenosine: A partial agonist of the growth hormone secretagogue receptor. Biochem. Biophys. Res. Commun. 276:2000;1306-1313
406. Smith R.G., Van der Ploeg L.H.T., Howard A.D., Feighner S.D., Cheng K., Hickey G.J., Wyvratt M.J. Jr., Fisher M.H., Nargund R.P., Patchett A.A. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 18:1997;621-645
407. Soto J.L., Castrillo J.L., Dominguez F., Dieguez C. Regulation of the pituitary-specific transcription factor GHF-1/PIT-1 messenger-ribonucleic-acid levels by growth hormone-secretagogues in rat anterior-pituitary-cells in monolayer-culture. Endocrinology. 136:1995;3863-3870
408. Sugino T., Hasegawa Y., Kikkawa Y., Yamaura J., Yamagishi M., Kurose Y., Kojima M., Kangawa K., Terashima Y. A transient ghrelin surge occurs just before feeding in a scheduled meal-fed sheep. Biochem. Biophys. Res. Commun. 295:2002;255-260
409. Sugino T., Yamaura J., Yamagishi M., Kurose Y., Kojima M., Kangawa K., Hasegawa Y., Terashima Y. Involvement of cholinergic neurons in the regulation of the ghrelin secretory response to feeding in sheep. Biochem. Biophys. Res. Commun. 304:2003;308-312
410. Sugino T., Yamaura J., Yamagishi M., Ogura A., Hayashi R., Kurose Y., Kojima M., Kangawa K., Hasegawa Y., Terashima Y. A transient surge of ghrelin secretion before feeding is modified by different feeding regimens in sheep. Biochem. Biophys. Res. Commun. 298:2002;785-788
411. Sun Y., Ahmed S., Smith R.G. Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell. Biol. 23:2003;7973-7981
412. Sun Y., Wang P., Zheng H., Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. USA. 2004
413. Suzuki H., Masaoka T., Hosoda H., Ota T., Minegishi Y., Nomura S., Kangawa K., Ishii H. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut. 53:2004;187-194
414. Suzuki A., Nakauchi H., Taniguchi H. Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells. Proc. Natl. Acad. Sci. USA. 100:2003;5034-5039
415. Svensson J., Lall S., Dickson S.L., Bengtsson B.-A., Romer J., Ahnfelt-Rhone I., Ohlsson C., Jansson J.O. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. J. Endocrinol. 165:2000;569-577
416. Svensson J., Monson J.P., Vetter T., Hansen T.K., Savine R., Kann P., Bex M., Reincke M., Hagen C., Beckers A., Ilondo M.M., Zdravkovic M., Bengtsson B.A., Korbonits M. Oral administration of the growth hormone secretagogue NN703
417. Svensson J., Ohlsson C., Jansson J.O., Murphy G., Wyss D., Krupa D., Cerchio K., Polvino W., Gertz B., Baylink D., Mohan S., Bengtsson B.-A. Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males. J. Bone Miner. Res. 13:1998;1158-1166
418. Szekeres P.G., Muir A.I., Spinage L.D., Miller J.E., Butler S.I., Smith A., Rennie G.I., Murdock P.R., Fitzgerald L.R., Wu H., McMillan L.J., Guerrera S., Vawter L., Elshourbagy N.A., Mooney J.L., Bergsma D.J., Wilson S., Chambers J.K. Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3. J. Biol. Chem. 275:2000;20247-20250
419. Tacke F., Brabant G., Kruck E., Horn R., Schoffski P., Hecker H., Manns M.P., Trautwein C. Ghrelin in chronic liver disease. J. Hepatol. 38:2003;447-454
420. Takaya K., Ariyasu H., Kanamoto N., Iwakura H., Yoshimoto A., Harada M., Mori K., Komatsu Y., Usui T., Shimatsu A., Ogawa Y., Hosoda K., Akamizu T., Kojima M., Kangawa K., Nakao K. Ghrelin strongly stimulates growth hormone release in humans. J. Clin. Endocrinol. Metab. 85:2000;4908-4911
421. Tamura H., Kamegai J., Shimizu T., Ishii S., Sugihara H., Oikawa S. Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats. Endocrinology. 143:2002;3268-3275
422. Tamura H., Kamegai J., Sugihara H., Kineman R.D., Frohman L.A., Wakabayashi I. Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression. J. Neuroendocrinol. 12:2000;481-485
423. Tan C.P., McKee K.K., Liu O., Palyha O.C., Feighner S.D., Hreniuk D.L., Smith R.G., Howard A.D. Cloning and characterisation of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors. Genomics. 52:1998;223-229
424. Tanaka M., Hayashida Y., Iguchi T., Nakao N., Nakai N., Nakashima K. Organization of the mouse ghrelin gene and promoter: occurrence of a short noncoding first exon. Endocrinology. 142:2001;3697-3700
425. Tanaka M., Hayashida Y., Nakao N., Nakai N., Nakashima K. Testis-specific and developmentally induced expression of a ghrelin gene-derived transcript that encodes a novel polypeptide in the mouse. Biochim. Biophys. Acta. 1522:2001;62-65
426. Tanaka K., Minoura H., Isobe T., Yonaha H., Kawato H., Wang D.F., Yoshida T., Kojima M., Kangawa K., Toyoda N. Ghrelin is involved in the decidualization of human endometrial stromal cells. J. Clin. Endocrinol. Metab. 88:2003;2335-2340
427. Tanaka M., Naruo T., Muranaga T., Yasuhara D., Shiiya T., Nakazato M., Matsukura S., Nozoe S. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur. J. Endocrinol. 146:2002;R1-R3
428. Tanaka M., Naruo T., Nagai N., Kuroki N., Shiiya T., Nakazato M., Matsukura S., Nozoe S. Habitual binge/purge behavior influences circulating ghrelin levels in eating disorders. J. Psychiatr. Res. 37:2003;17-22
429. Tanaka M., Naruo T., Yasuhara D., Tatebe Y., Nagai N., Shiiya T., Nakazato M., Matsukura S., Nozoe S. Fasting plasma ghrelin levels in subtypes of anorexia nervosa. Psychoneuroendocrinology. 28:2003;829-835
430. Tannenbaum G.S., Epelbaum J., Bowers C.Y. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology. 144:2003;967-974
431. Tannenbaum G.S., Lapointe M., Beaudet A., Howard A.D. Expression of growth hormone secretagogue receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology. 139:1998;4420-4423
432. Tassone F., Broglio F., Destefanis S., Rovere S., Benso A., Gottero C., Prodam F., Rossetto R., Gauna C., van der Lely A.J., Ghigo E., Maccario M. Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. J. Clin. Endocrinol. Metab. 88:2003;5478-5483
433. Tena-Sempere M., Barreiro M.L., Gonzalez L.C., Gaytan F., Zhang F.P., Caminos J.E., Pinilla L., Casanueva F.F., Dieguez C., Aguilar E. Novel expression and functional role of ghrelin in rat testis. Endocrinology. 143:2002;717-725
434. Thomas G.B., Bennett P.A., Carmignac D.F., Robinson I.C.A.F. Glucocorticoid regulation of growth hormone (GH) secretagogue- induced growth responses and GH secretagogue receptor expression in the rat. Growth Horm. IGF Res. 10:2000;45-52
435. Thompson N.M., Davies J.S., Mode A., Houston P.A., Wells T. Pattern-dependent suppression of growth hormone (GH) pulsatility by ghrelin and GHRP-6 in moderately GH deficient rats. Endocrinology. 144:2003;4859-4867
436. Thompson N.M., Gill D.A., Davies R., Loveridge N., Houston P.A., Robinson I.C., Wells T. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of GHS-R1a. Endocrinology. 145:2004;232-242
437. Thorner M.O., Chapman I.M., Gaylinn B.D., Pezzoli S.S., Hartman M.L. Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging. Recent Prog. Horm. Res. 52:1997;215-244
438. Tivesten A., Bollano E., Caidahl K., Kujacic V., Sun X.Y., Hedner T., Hjalmarson A., Bengtsson B.-A., Isgaard J. The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. Endocrinology. 141:2000;60-66
439. Tolle V., Kadem M., Bluet-Pajot M.T., Frere D., Foulon C., Bossu C., Dardennes R., Mounier C., Zizzari P., Lang F., Epelbaum J., Estour B. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J. Clin. Endocrinol. Metab. 88:2003;109-116
440. Tolle V., Zizzari P., Tomasetto C., Rio M.C., Epelbaum J., Bluet-Pajot M.T. In vivo and in vitro effects of ghrelin/motilin-related peptide on growth hormone secretion in the rat. Neuroendocrinology. 73:2001;54-61
441. Tomasetto C., Karam S.M., Ribieras S., Masson R., Lefebvre O., Staub A., Alexander G., Chenard M.P., Rio M.C. Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology. 119:2000;395-405
442. Torsello A., Bresciani E., Rossoni G., Avallone R., Tulipano G., Cocchi D., Bulgarelli I., Deghenghi R., Berti F., Locatelli V. Ghrelin plays a minor role in the physiological control of cardiac function in the rat. Endocrinology. 144:2003;1787-1792
443. Torsello A., Ghe' C., Bresciani E., Catapano F., Ghigo E., Deghenghi R., Locatelli V., Muccioli G. Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo. Endocrinology. 143:2002;1968
444. Torsello A., Locatelli V., Melis M.R., Succu S., Spano M.S., Deghenghi R., Muller E.E., Argiolas A. Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: Indication for multiple growth hormone secretagogue receptor subtypes. Neuroendocrinology. 72:2000;327-332
445. Torsello A., Luoni M., Schweiger F., Grilli R., Guidi M., Bresciani E., Deghenghi R., Müller E.E., Locatelli V. Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release. Eur. J. Pharmacol. 360:1998;123-129
446. Torsello A., Scibona B., Leo G., Bresciani E., Avallone R., Bulgarelli I., Luoni M., Zoli M., Rindi G., Cocchi D., Locatelli V. Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat. Neuroendocrinology. 77:2003;91-99
447. Toshinai K., Date Y., Murakami N., Shimada M., Mondal M.S., Shimbara T., Guan J.L., Wang Q.P., Funahashi H., Sakurai T., Shioda S., Matsukura S., Kangawa K., Nakazato M. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology. 144:2003;1506-1512
448. Toshinai K., Mondal M.S., Nakazato M., Date Y., Murakami N., Kojima M., Kangawa K., Matsukura S. Upregulation of ghrelin expression in the stomach upon fasting, insulin- induced hypoglycemia, and leptin administration. Biochem. Biophys. Res. Commun. 281:2001;1220-1225
449. Traebert M., Riediger T., Whitebread S., Scharrer E., Schmid H.A. Ghrelin acts on leptin-responsive neurones in the rat arcuate nucleus. J. Neuroendocrinol. 14:2002;580-586
450. Tritos N.A., Kokkinos A., Lampadariou E., Alexiou E., Katsilambros N., Maratos-Flier E. Cerebrospinal fluid ghrelin is negatively associated with body mass index. J. Clin. Endocrinol. Metab. 88:2003;2943-2946
451. Trudel L., Tomasetto C., Rio M.C., Bouin M., Plourde V., Eberling P., Poitras P. Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am. J. Physiol. Gastrointest. Liver Physiol. 282:2002;G948-G952
452. Tschöp M., Flora D.B., Mayer J.P., Heiman M.L. Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats. Obes. Res. 10:2002;991-999
453. Tschöp M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature. 407:2000;908-913
454. Tschöp M., Wawarta R., Riepl R.L., Friedrich S., Bidlingmaier M., Landgraf R., Folwaczny C. Post-prandial decrease of circulating human ghrelin levels. J. Endocrinol. Invest. 24:2001;RC19-RC21
455. Tschöp M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes. 50:2001;707-709
456. 2) in children with GH insufficiency and idiopathic short stature. Metabolism. 44:1995;1199-1204
457. Tullin S., Hansen B.S., Ankersen M., Moller J., Von Cappelen K.A., Thim L. Adenosine is an agonist of the growth hormone secretagogue receptor. Endocrinology. 141:2000;3397-3402
458. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M., Meeran K., Choi S.J., Taylor G.M., Heath M.M., Lambert P.D., Wilding J.P., Smith D.M., Ghatei M.A., Herbert J., Bloom S.R. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 379:1996;69-72
459. Ukkola O., Kesäniemi Y.A. Preproghrelin Leu72Met polymorphism in patients with type 2 diabetes mellitus. J. Intern. Med. 254:2003;391-394
460. Ukkola O., Ravussin E., Jacobson P., Perusse L., Rankinen T., Tschöp M., Heiman M.L., Leon A.S., Rao D.C., Skinner J.S., Wilmore J.H., Sjostrom L., Bouchard C. Role of ghrelin polymorphisms in obesity based on three different studies. Obes. Res. 10:2002;782-791
461. Ukkola O., Ravussin E., Jacobson P., Snyder E.E., Chagnon M., Sjostrom L., Bouchard C. Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J. Clin. Endocrinol. Metab. 86:2001;3996-3999
462. Van den Berghe G., Baxter R.C., Weekers F., Wouters P., Bowers C.Y., Iranmanesh A., Veldhuis J.D., Bouillon R. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin. Endocrinol. (Oxf.). 56:2002;655-669
463. A.J. van der Lely, M. Tschöp, M.L. Heiman, E. Ghigo, Biological, physiological, pathophysiological and pharmacological aspects of ghrelin, Endocr. Rev. (2004) (in press)
464. Veeraragavan K., Sethumadhavan K., Bowers C.Y. Growth hormone-releasing peptide (GHRP) binding to porcine anterior pituitary and hypothalamic membranes. Life Sci. 50:1992;1149-1155
465. Volante M., Allia E., Fulcheri E., Cassoni P., Ghigo E., Muccioli G., Papotti M. Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. Am. J. Pathol. 162:2003;645-654
466. Volante M., Allia E., Gugliotta P., Funaro A., Broglio F., Deghenghi R., Muccioli G., Ghigo E., Papotti M. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J. Clin. Endocrinol. Metab. 87:2002;1300-1308
467. Volante M., Fulcheri E., Allia E., Cerrato M., Pucci A., Papotti M. Ghrelin expression in fetal, infant, and adult human lung. J. Histochem. Cytochem. 50:2002;1013-1021
468. Wajnrajch M.P., Ten I.S., Gertner J.M., eibel R.L. Genomic organisation of the human ghrelin gene. J. Endocr. Genetics. 1:2000;231-233
469. Wang H.J., Geller F., Dempfle A., Schauble N., Friedel S., Lichtner P., Fontenla-Horro F., Wudy S., Hagemann S., Gortner L., Huse K., Remschmidt H., Bettecken T., Meitinger T., Schafer H., Hebebrand J., Hinney A. Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature. J. Clin. Endocrinol. Metab. 89:2004;157-162
470. Wang L., Saint-Pierre D.H., Tache Y. Peripheral ghrelin selectively increases Fos expression in neuropeptide Y - synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci. Lett. 325:2002;47-51
471. Weekers F., Van Herck E., Isgaard J., Van den Berghe G. Pretreatment with growth hormone-releasing peptide-2 directly protects against the diastolic dysfunction of myocardial stunning in an isolated, blood-perfused rabbit heart model. Endocrinology. 141:2000;3993-3999
472. Weigle D.S., Cummings D.E., Newby P.D., Breen P.A., Frayo R.S., Matthys C.C., Callahan H.S., Purnell J.Q. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J. Clin. Endocrinol. Metab. 88:2003;1577-1586
473. Weikel J.C., Wichniak A., Ising M., Brunner H., Friess E., Held K., Mathias S., Schmid D.A., Uhr M., Steiger A. Ghrelin promotes slow-wave sleep in man. Am. J. Physiol. Endocrinol. Metab. 284:2002;E407-E415
474. Wells T., Houston P.A. Skeletal growth acceleration with growth hormone secretagogues in transgenic growth retarded rats: pattern-dependent effects and mechanisms of desensitization. J. Neuroendocrinol. 13:2001;496-504
475. Wierup N., Svensson H., Mulder H., Sundler F. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul. Pept. 107:2002;63-69
476. Wiley K.E., Davenport A.P. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br. J Pharmacol. 136:2002;1146-1152
477. Willesen M.G., Kristensen P., Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology. 70:1999;306-316
478. Williams D.L., Cummings D.E., Grill H.J., Kaplan J.M. Meal-related ghrelin suppression requires postgastric feedback. Endocrinology. 144:2003;2765-2767
479. Williams D.L., Grill H.J., Cummings D.E., Kaplan J.M. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology. 144:2003;5184-5187
480. Wisse B.E., Frayo R.S., Schwartz M.W., Cummings D.E. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology. 142:2001;3292-3301
481. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L., Cohen M.A., Batterham R.L., Taheri S., Stanley S.A., Ghatei M.A., Bloom S.R. Ghrelin causes hyperphagia and obesity in rats. Diabetes. 50:2001;2540-2547
482. Wren A.M., Small C.J., Fribbens C.V., Neary N.M., Ward H.L., Seal L.J., Ghatei M.A., Bloom S.R. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology. 76:2002;316-324
483. A.M. Wren, C.J. Small, E.L. Thomas, C.R. Abbott, M.A. Ghatei, J.D. Bell, S.R. Bloom, Continuous subcutaneous administration of ghrelin results in accumulation of adipose tissue, independent of hyperphagia or body weight gain, Endocrine Abstracts Spring. (2004) OC35
484. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., Kennedy A.R., Roberts G.H., Morgan D.G., Ghatei M.A., Bloom S.R. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 141:2000;4325-4328
485. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., Tominaga M., Yagami K., Sugiyama F., Goto K., Yanagisawa M., Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron. 38:2003;701-713
486. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8:2002;1288-1295
487. Yasuda T., Masaki T., Kakuma T., Yoshimatsu H. Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats. Neurosci. Lett. 349:2003;75-78
488. Yoshimoto A., Mori K., Sugawara A., Mukoyama M., Yahata K., Suganami T., Takaya K., Hosoda H., Kojima M., Kangawa K., Nakao K. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J. Am. Soc. Nephrol. 13:2002;2748-2752
489. H. Yu, F. Cassorla, A.N. Tiulpakov, Y.-Z. Shi, N. Setian, B.B. Bercu, A. Arango, G. Kletter, O.H. Pescovitz, J. DiMartino, D. Krupa, M. Cambria, P. Kanojia, M.A. Bach, A double blind placebo-controlled efficacy trial of an oral growth hormone (GH) secretagogue (MK-0677) in GH deficient (GHD) children, in: Proceedings of the 80th Annual Meeting of the Endocrine Society, OR24-6, 1998
490. Zdravkovic M., Sogaard B., Ynddal L., Christiansen T., Agerso H., Thomsen M.S., Falch J.E., Ilondo M.M. The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers. Growth Horm. IGF Res. 10:2000;193-198
491. Zhang W., Chen M., Chen X., Segura B.J., Mulholland M.W. Inhibition of pancreatic protein secretion by ghrelin in the rat. J. Physiol. (Lond.). 537:2001;231-236
492. Zhang W., Lin T.R., Hu Y., Fan Y., Zhao L., Mulholland M.W. Activation of c-fos expression in the rat inferior olivary nucleus by ghrelin. Neurosci. Lett. 353:2003;157-160